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Abstract 
 
Sunyong Tang 
 
TRANSGENIC USE OF SMAD7 TO SUPPRESS TGFβ SIGNALING DURING 
MOUSE DEVELOPMENT 
 
Neural crest cells (NCC) are a multipotent population of cells that form at the 
dorsal region of neural tube, migrate and contribute to a vast array of embryonic 
structures, including the majority of the head, the septum of the cardiac outflow 
tract (OFT), smooth muscle subpopulations, sympathetic nervous system and 
many other organs. Anomalous NCC morphogenesis is responsible for a wide 
variety of congenital defects. Importantly, several individual members of the 
TGFβ superfamily have been shown to play essential roles in various aspects of 
normal NCC development. However, it remains unclear what role Smad7, a 
negative regulator of TGFβ superfamily signaling, plays during development and 
moreover what the spatiotemporal effects are of combined suppression of TGFβ 
superfamily signaling during NCC formation and colonization of the developing 
embryo. Using a cre/loxP three-component triple transgenic system, expression 
of Smad7 was induced via doxycycline in the majority of pre- and post-migratory 
NCC lineages (via Wnt1-Cre mice). Further, expression of Smad7 was induced 
via doxycycline in a subset of post-migratory NCC lineages (via Periostin-Cre 
mice, after the NCC had reached their target organs and undergone 
differentiation). Induction of Smad7 within NCC significantly suppressed TGFβ 
 vii
superfamily signaling, as revealed via diminished phosphorylation levels of both 
Smad1/5/8 and Smad2/3 in vivo. This resulted in subsequent loss of NCC-
derived craniofacial, pharyngeal and cardiac OFT cushion tissues. ROSA26r 
NCC lineage mapping demonstrated that cardiac NCC emigration and initial 
migration were unaffected, but subsequent colonization of the OFT was 
significantly reduced. At the cellular level, increased cell death was observed, but 
cell proliferation and NCC-derived smooth muscle differentiation were unaltered. 
Molecular analysis demonstrated that Smad7 induction resulted in selective 
increased phospho-p38 levels, which in turn resulted in the observed initiation of 
apoptosis in trigenic mutant embryos. Taken together, these data demonstrate 
that tightly regulated TGFβ superfamily signaling is essential for normal 
craniofacial and cardiac NCC colonization and cell survival in vivo. 
 
 
Simon J. Conway, Ph.D., Chair 
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Chapter I:  Introduction 
 
A. TGFβ superfamily signaling pathway 
The Transforming Growth Factor Beta (TGFβ) superfamily consists of more than 
30 ligand proteins [1] including TGFβ isoforms, activins, Bone Morphogenetic 
Proteins (BMP)s and other ligands. Members of the TGFβ superfamily family 
represent structurally similar, but functionally diverse growth factors which play a 
variety of biological roles during cell proliferation, differentiation, apoptosis and 
many other tissue remodeling processes, including early embryogenesis and 
heart morphogenesis.  
 
The signaling by TGFβ superfamily members is initiated by binding of ligands to 
the type II receptor (Fig. 1), which then recruits type I receptor and 
phosphorylates and activates it [2]. There are different type I and II receptors that 
can interact with a set of distinct co-receptors, adding to the signaling complexity. 
Activation of these serine/threonine kinase receptors leads to signal propagation 
by phosphorylation of Receptor- Sma- And Mad-Related Proteins (R-Smad)s, 
with Smad2 and 3 mediating the activities of TGFβ isoforms and activins, and 
Smads 1, 5, and 8, the activities of BMPs. Phosphorylated R-Smads form 
complexes with Smad4, which is common to both the TGFβ and BMP signaling 
pathways, the complexes then translocate to the nucleus to regulate gene 
transcription. In contrast to the R-Smads, the inhibitory I-Smads (Smad6 and 7) 
negatively regulate TGFβ superfamily signaling in vitro. While Smad6 is a 
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specific negative regulator of BMP signaling [3-4], Smad7 negatively regulates 
both TGFβ and BMP signaling [4-8]. He [9] and Kuang [10] showed that over-
expression of Smad7 in the skin and pancreas, respectively, specifically 
disrupted TGFβ pathway signaling in vivo. 
 
B. Neural crest development 
Neural crest cells (NCC) are a pluripotent cell population that gives rise to and 
influences the development of a diverse array of tissues in the developing 
embryo. They are a transient population of cells formed during early vertebrate 
embryonic development on the dorsal side of the developing neural tube, where 
it contacts with the surface ectoderm (Fig. 2A). NCC are highly plastic and are 
known to be dependent on cues from the extracellular environment, such as 
sonic hedgehog, Wingless-Type Mmtv Integration Site Family (WNT) members, 
BMPs and Fibroblast Growth Factors (FGF)s to differentiate into defined cell 
types [11]. After neurulation, NCCs undergo epithelial to mesenchymal 
transformation, delaminate and migrate (Fig. 2B) along defined pathways to 
colonize  and contribute to the formation of a variety of target tissues and organs 
[12-13].  
 
Cranial NCC, located at the anterior neural tube (Fig. 2C), migrate and populate 
the first, second and third pharyngeal arches and frontonasal mass. After the 
migration, these cells differentiate into a number of structures, including cranial 
neurons, glia, cartilage, bone and connective tissues of the face [14-19]. Cardiac 
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NCC, located at the regions from the otic vesicle to the third somite (Fig. 2C), 
migrate through the third, fourth and sixth pharyngeal arches to the OFT, and 
contribute to the formation of smooth muscle cells surrounding the pharyngeal 
arch arteries and aorticopulmonary septum [13, 20]. At the trunk level, NCC 
migrate out of neural tube (Fig. 2C) and give rise to many structures such as 
dorsal root ganglia, sympathetic ganglia, the adrenal medulla, and the nerve 
clusters surrounding the aorta [18, 20-21].  
 
C. Heart development 
The heart is the first functional organ. The vertebrate heart arises from cardiac 
progenitors and extracardiac sources. At embryonic day 7.75 (E7.75) in mouse, 
cardiac progenitors form a cardiac crest at the ventral side. At E9.5, cardiac 
progenitors give rise to the primitive linearized heart tube (Fig. 3) composed of an 
outer layer of myocardium and an inner layer of endocardial cells, separated by 
an extensive extracellular matrix referred to as the cardiac jelly. Subsequently, 
the primitive heart tube generates a right-side bend and forms segments. These 
segments will give rise to OFT, ventricles, atrioventricular canal (AVC), atria and 
inflow tract, anteroposteriorly. Proper development of heart chambers and valves 
requires the formation of endocardial cushion tissue in the AVC and OFT 
segments. The endocardial cells at the OFT and AVC undergo epithelial to 
mesenchymal transformation (EMT) by the signals from the underlying 
myocardium and migrate into the acellular cardiac jelly. Locally expanded cardiac 
jelly and mesenchymal cells are referred to as cardiac cushions. Neural crest 
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cells and other extracardiac sources also contribute mesenchymal cells to the 
formation of endocardial cushions [22-23]. EMT occurs at around E9.5 in AVC 
and E10 in OFT. During EMT, endocardial cells down-regulate VE-cadherin and 
PECAM expression and express SM-α-actin [24]. Once transformed, the 
mesenchymal cells proliferate and invade the cardiac jelly. Cardiac cushion 
formation ends around E10.5 and E11 in the AVC and OFT, respectively. Heart 
valves and septal structures are derived from those cardiac cushions. The OFT 
septum between aorta and pulmonary trunk starts to form at E11.5. The 
extracardiac neural crest cells contribute to its formation [20, 25-26]. 
 
As development proceeds, aorticopulmonary septum, AV septum and ventricular 
septum come into alignment, resulting in completion of the four-chambered heart. 
The last major morphogenetic event is valve formation. The cardiac cushions 
undergo further maturation and remodeling to form mature heart valves. The 
aortic and pulmonary valves are derived from OFT endocardial cushion, and the 
mitral and tricuspid valves are from the AV endocardial cushion. Thus, along with 
the formation of heart conduction system, the linearized primitive tubular heart 
has become a dual-channel, synchronously beating four chambered heart with 
one-way valves. 
 
D. Congenital heart defects 
Heart defects are the leading cause of birth defect-related deaths. About 40,000 
(~1%) infants are born with heart defects each year in the United States, which 
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makes it the number 1 birth defect in the US (AHA, 2005). Defects in cardiac 
valves and associated structures are the most common subtypes, accounting for 
25% to 30% of all cardiovascular malformations [27]. The high prevalence of 
congenital heart defects demands our thorough understanding of the underlying 
molecular mechanisms of heart development and remodeling. 
 
E. TGFβ superfamily signaling role in neural crest development 
Several of the above mentioned TGFβ signaling components have been 
manipulated in vivo in the developing neural crest. Inactivation of genes encoding 
TGFβ2 and TGFβ3 in mice resulted in severe craniofacial malformations, while 
BMP over-expression or blocking BMP by its inhibitor Noggin in developing 
chicken affected sympathetic ganglia formation [28-31]. BMP4 and BMP7 have 
been shown to be the growth factors produced by dorsal aorta to trigger the 
neural crest to undergo adrenergic differentiation normally [28]. 
 
With respect to receptors for TGFβ family factors, TGFβ type II receptor (Tgbfr2) 
and TGFβ type I receptor (Alk5) inactivation in the neural crest caused extensive 
craniofacial defects, such as cleft palate, and cardiovascular malformations 
including aortic arch patterning deficiencies, persistent truncus arteriosus, and 
septal defects [30, 32-36]. Similar defects resulted from neural crest specific 
deletion of receptors mediating BMP responses [37-39]. 
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In addition, ablation of Smad4 or over-expression of Smad7 in neural crest 
lineages leads to massive cell death and thus malformations in both craniofacial 
and cardiovascular neural crest derivatives [40-42] and to reduced size and 
altered patterning of trigeminal ganglia [41]. All these data demonstrate that 
TGFβ superfamily signaling plays important roles in neural crest development. 
 
F. TGFβ superfamily signaling role in endocardial cushion maturation and 
heart valve homeostasis 
A number of TGFβ superfamily members have been implicated in heart 
development. High level TGFβ1 expression occurs in the endothelial cells of the 
heart valves from E8.0 until after birth [43]. At E10.5, TGFβ2 mRNA expression 
in the heart is limited to the AVC and OFT myocardium/cushions; from E12.5-
14.5, TGFβ2 is no longer expressed in myocardium, but is expressed in the 
mesenchymal cells [44]. Cardiac TGFβ3 is limited to mesenchymal cells at the 
base of the heart valves from E14.5-16.5 [44]. At E10.5, Bmp4 expression is 
restricted to the myocardium of OFT, but not the AVC [45]. In addition, strong 
Bmp4 expression is also found in OFT myocardium E12-14 [46]. At E10.5, Bmp6 
is expressed in OFT myocardium [45] and at E12.5 Bmp6 is expressed in OFT 
cushions [47]. High level and ubiquitous Bmp7 expression is found throughout 
the myocardium of the heart tube from E8.5-15.5 [48].  
 
These expression patterns of TGFβ ligands correlate with valve development. 
Mice lacking either TGFβ1 or TGFβ3, however, do not exhibit cardiac defects 
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[49-50]. Bmp4 null mice die by E8.5, excluding the possibility to study heart 
development [51]. Mice with single mutations of either Bmp5, Bmp6 or Bmp7 did 
not display any heart defects [52-54]. An explanation for these unexpected 
phenotypes includes functional redundancy among TGFβ superfamily ligands. 
Indeed, double knock out of Bmp5 and 7 in mice demonstrate delayed cardiac 
development and lack of cushion formation [48]. In addition, OFT cushion 
morphogenesis is delayed in Bmp6 and 7 double null mice [47]. 
 
Both Smad6 and Smad7 are predominantly expressed in the developing OFT 
and AV cushion between E9.5 to E13.5 [55]. Smad6 expression remains in 
cardiac valves and OFT after birth and adulthood and null mice have defects in 
cardiovascular system [56]. Dr. Conway’s lab has shown that Smad6 null hearts 
exhibit persistent truncus (PTA) defects and enlarged cushions/heart valves [57]. 
Smad7 mutant mice with exon 1 deletion have altered B-cell responses but are 
not known to exhibit any cardiovascular defects [58]. However, one major caveat 
of this mouse model was deleting the exon 1 of Smad7 gene did not completely 
abolish the repressing ability of Smad7 on TGFβ signaling. Another Smad7 null 
mouse model [59], by deleting the indispensable exon 2, demonstrated Smad7 is 
required for normal cardiac function and OFT development. 
 
G. Hypothesis 
After formed at the dorsal neural tube, NCC migrate away from neural tube and 
colonize their target organs, there they differentiate into a variety of specialized 
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cells. Many research studies have shown that TGFβ superfamily signaling is 
required for NCC development [28-31]. However, all these research only focused 
on the role of TGFβ superfamily signaling in pre-migratory NCC. The distinct 
developmental phases of NCC development suggest NCC may or may not 
require TGFβ superfamily signaling at each stage. I hypothesize that TGFβ 
superfamily signaling plays an essential role at pre-migratory, post-migratory, 
differentiating, and post-differentiation NCC development. To test this hypothesis, 
I used Smad7 as a tool to study the roles of TGFβ superfamily signaling at 
various NCC developmental phases via a doxycycline inducible tissue specific 
transgenic mouse system. 
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Figure 1. Model of TGFβ superfamily signaling pathway. (Adapted from 
Armstrong and Bischoff [60]) 
Extracellular 
space 
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Figure 2. Neural crest development. (Pictures are obtained from internet 
http://www.ratbehavior.org/images/NeuralCrest.jpg, 
http://www.nature.com/nature/journal/v407/n6801/fig_tab/407227a0_F1.html,  
http://www.stonybrook.edu/biochem/BIOCHEM/facultypages/holdener/c112k.html 
respectively) 
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Figure 3. Heart development model. (Courtesy to Eric Olson [61]) 
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Chapter II: Trigenic neural crest-restricted Smad7 overexpression results in 
congenital craniofacial and cardiovascular defects 
 
Abstract 
Smad7 is a negative regulator of TGFβ superfamily signaling. Using a three-
component triple transgenic system, expression of Smad7 was induced via 
doxycycline within the neural crest lineages at pre- and post-migratory stages. 
Consistent with its role in negatively regulating both TGFβ and BMP signaling in 
vitro, induction of Smad7 within the NCC significantly suppressed 
phosphorylation levels of both Smad1/5/8 and Smad2/3 in vivo, resulting in 
subsequent loss of NCC-derived craniofacial, pharyngeal and cardiac OFT 
cushion tissues. At the cellular level, increased cell death was observed in 
pharyngeal arches. However, cell proliferation and NCC-derived smooth muscle 
differentiation were unaltered. NCC lineage mapping demonstrated that cardiac 
NCC emigration and initial migration were not affected, but subsequent 
colonization of the OFT was significantly reduced. Induction of Smad7 in post-
migratory NCC resulted in cardiac OFT anomalies and interventricular septal 
chamber septation defects, suggesting that TGFβ superfamily signaling is also 
essential for cardiac NCC to govern normal cardiac development at post-
migratory stage. Taken together, the data show that tightly regulated TGFβ 
superfamily signaling plays an essential role during craniofacial and cardiac NCC 
colonization and cell survival in vivo. 
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Introduction 
Neural crest cells (NCC) are a transient population of cells created during higher 
vertebrate early embryonic development. During neurulation, NCC undergo 
successive epithelial-to-mesenchymal transformation along the cranial-caudal 
embryonic axis [62], delaminate and migrate along defined pathways to 
contribute to the formation of a wide variety target tissues, including neurons and 
glia of the peripheral nervous system, melanocytes, smooth muscle cells and 
most craniofacial cartilages and bones [12, 14, 63]. NCC also contribute crucial 
cell populations to several thoracic tissues, including the developing aortic arch 
arteries (AAA) and OFT of the heart [13, 20, 64-65]. Despite the diversity of NCC 
fates, they are divided broadly into cranial, cardiac and trunk NCC populations 
based on their site of origin and ability to colonize target tissues and organs [12-
13, 15-16, 19].  
 
TGFβ superfamily members are obligatory growth factors for early 
embryogenesis and heart morphogenesis, and play diverse biological roles 
during cell proliferation, differentiation, apoptosis and many other tissue 
remodeling processes. There are over 30 members in TGFβ superfamily in 
mammals, including BMPs, TGFβs, activins and other cytokines [1]. Signaling via 
the TGFβ superfamily initiates by binding of ligands to the membrane bound type 
II receptor, which then recruits and activates the type I receptor. Activated type I 
receptor then phosphorylates regulatory (R)-Smads (Smad1, 2, 3, 5 or 8), which 
subsequently form a complex with the co-Smad, Smad4. The complex then 
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translocates into nucleus to regulate gene transcription [66-68]. In contrast to the 
R-Smads, the inhibitory (I)-Smads (Smad6 and 7) negatively regulate TGFβ 
superfamily signaling in vitro. While Smad6 negatively regulates BMP signaling 
[3-4], Smad7 negatively regulates both TGFβ and BMP signaling [4-8]. BMP 
signaling (particularly via BMP2/BMP4 ligands and their receptors Alk2, Alk3, 
Alk4) has been implicated in promoting NCC induction, maintenance, migration 
and differentiation in several different model organisms [21, 37-39, 69-71]. 
Similarly, there is accumulating evidence that TGFβ signaling in NCC is critical, 
as NCC-restricted deletion of  type I (Alk5)  and type II receptors results in a 
spectrum of defects in the craniofacial, pharyngeal and cardiac regions  [30, 32, 
34, 36]. In addition, previous studies have shown that Wnt1-Cre mediated 
conditional knockout of Smad4 within the NCC results in craniofacial, pharyngeal 
and cardiac malformations [40-41, 72-73], demonstrating that NCC-specific 
Smad4-mediated TGFβ/BMP signal transduction is required for NCC normal 
development. Overall, TGFβ superfamily signaling has been strongly implicated 
in NCC development, but its detailed in utero molecular mechanisms are still 
poorly understood due to the large number of family members with wide range of 
overlapping functions, and complex receptor-ligand associations. Due to 
Smad7’s unique role in repressing both BMP and TGFβ signaling and its 
contrasting role to that of Smad4 within TGFβ superfamily signaling, we 
hypothesized that Wnt1-Cre mediated Smad7 overexpression  would phenocopy 
Wnt1-Cre mediated loss of Smad4 function.  
 
 15
To test this hypothesis and examine further the spatiotemporal role of TGFβ 
superfamily signaling during NCC morphogenesis and the temporal consequence 
of TGFβ superfamily inhibition during development, we generated a three-
component triple transgenic Smad7 expression mouse model (herein termed 
trigenic) based on Cre/loxP recombination (to induce spatially-restricted Smad7 
expression) and doxycycline-inducible control elements (to temporally regulate 
Smad7 expression). As Smad7 has already been demonstrated to negatively 
regulate both TGFβ and BMP signaling in vivo in mammalian adult tissues, B 
cells, retinal pigment epithelium and Xenopus explant assays [4-8], we are using 
spatiotemporally-regulated Smad7 induction as a tool to attenuate TGFβ 
superfamily signaling in utero within restricted cell lineages and defined 
developmental temporal windows. Results reported here demonstrate that pre-
migratory Smad7 induction attenuates both TGFβ and BMP signaling by 
suppressing R-Smad phosphorylation, resulting in elevated NCC death, 
diminished NCC colonization of craniofacial, pharyngeal, cardiac tissues, 
dysregulated epithelial-mesenchymal interactions and in utero lethality. 
Additionally, Smad7 induction in post-migratory cardiac NCC results in isolated 
intraventricular septal defects and neonatal lethality. This work demonstrates that 
tightly regulated TGFβ superfamily signaling plays an essential role during both 
craniofacial and cardiac NCC colonization and cell survival in vivo. 
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Materials & Methods 
Conditional neural crest-specific trigenic mice:  
In the construct used to generate (tetO)-Smad7 transgenic mice, myc-tagged 
Smad7 cDNA [10] was inserted between a (tetO)7CMV minimal promoter and 
the bovine growth factor polyadenylation signal sequence (bGHpA) within the 
pUHD10-3 vector (generously provided by Dr. Andras Nagy, Samuel Lunenfeld 
Research Institute [74]). Following diagnostic restriction digest verification and 
sequencing, the linearized construct was given to the IU Transgenic Core Facility 
for microinjection into inbred C3HeB/FeJ zygotes to obtain transgenic founders 
as described [75]. Forward primer 5’- ATCCACGCTGTTTTGACCTC-3’ and 
reverse primer 5’- GAGCGCAGATCGTTTGGT-3’ were used for genotyping tetO-
Smad7 transgenic offspring via PCR using mouse genomic DNA from tail using 
established protocols [76]. Three independent lines were generated and all three 
were viable up to two years of age. In order to generate triple transgenic 
doxycycline-inducible mice, tetO-Smad7 mice were intercrossed with both the 
reverse tetracycline transactivator Rosa26rtTA-EGFP (R26rtTA-EGFP) (JaxLab stock 
#005670) and Wnt1-Cre [20] mice. For the lineage mapping studies, Rosa26 
reporter (R26r) mice (JaxLab stock #003474) were intercrossed with the 
trigenics. Genotyping was carried out using PCR primers specific for each 
transgene (http://www.jax.org; [20]). All mice were maintained on mixed genetic 
backgrounds and age-matched littermates were used as appropriate controls. To 
induce Smad7 transgene expression in trigenic embryos, pregnant females were 
given doxycycline administered in green dyed food pellets at a concentration of 
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200mg/kg (Bio-Serv) for specified time periods. Mice were maintained under 
specific-pathogen-free conditions with a 12 hours light/dark cycle. The animal 
use protocols were approved by the Institutional Animal Care and Use 
Committee at IUPUI (study #3301). 
 
RNA and Protein Analysis:  
In order to verify Smad7 cDNA induction by RT-PCR, cDNA was synthesized 
from RNA isolated from individual control (trigenic mice without doxycycline food) 
and mutant (trigenic mice fed doxycycline food) embryonic day 10.5 (E10.5) 
whole embryos (n = 4 embryos of each treatment) using a Superscript-II kit 
(Invitrogen) with 5μg RNA and oligo(dT) primer. cDNAs were amplified with 
specific Smad7 primers (30 cycles; forward primer 5’- 
GCATTCCTCGGAAGTCAAGA-3’ and reverse primer 5’-
TTGTTGTCCGAATTGAGCTG-3’) and normalized with GAPDH (16 cycles; 
Glyceraldehyde-3-phosphate dehydrogenase) as described previously [77]. In 
order to verify myc-tagged Smad7 protein induction and suppressive effects upon 
TGFβ superfamily signaling via western blotting, doxycycline-fed E10.5 embryos 
were homogenized on ice in RIPA buffer with 1% phosphatase inhibitor mixture 
(Sigma). Proteins were blotted onto PVDF membrane and the following 
antibodies used: Smad1 (1:2000, Santa Cruz Biotech, sc-81378), phospho-
Smad1/5/8 (1:1000, Cell signaling, 9511), Smad2/3 (1:2,000, Santa Cruz 
Biotech, sc-8332), phospho-Smad2 (1:1000, Cell signaling, 3101), Myc (1:5000, 
Santa Cruz Biotech, A-14), αTubulin (1:10000, Sigma, T-5168). Primary antibody 
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binding as visualized by HRP-conjugated secondary antibodies and enhanced 
chemiluminescence (Amersham, GE Healthcare Biosciences). Densitometry was 
quantified from at least 3 samples and the combined data graphically displayed.  
 
Histological Analysis, X-Gal Staining and Immunohistochemistry:  
Tissue isolation, 4% paraformaldehyde fixation, processing, paraffin embedding, 
H&E staining, and whole mount detection of R26r indicator β-galactosidase 
activity were performed as described [75-77]. Following whole mount lacZ 
staining, embryos were dehydrated through alcohol and embedded in paraffin. 
Sections (n= 3 individual embryos of each genotype) were cut at 10μm thickness 
and counterstained with Eosin. As our mice lines are not isogenic, doxycycline-
fed single and double transgenic age-matched littermates were used as negative 
controls. Immunostaining was carried out using ABC kit (Vectorstain) with DAB 
and hydrogen peroxide chromogens as described previously [78]. The following 
primary antibodies were used to assess neural crest differentiation and TGFβ 
superfamily signaling: α-smooth muscle actin (1:5000, αSMA, Sigma), phospho-
Smad1/5/8 (1:750, Cell Signaling, 9511), phospho-Smad2 (1:1500, Cell 
Signaling, 3101). Negative controls were obtained by substituting the primary 
antibody with serum at 1:150 dilution and positive staining within serial sections 
was examined using at least three individual embryos of each genotype at each 
developmental stage. 
 
 
 19
Apoptosis and cell proliferation:  
Apoptotic cells were detected in paraffinembedded tissue sections using TdT-
FragELTM DNA Fragmentation Detection Kit (Calbiochem). Cell proliferation was 
immunodetected using the Ki67 antibody (1:25, DakoCytomation). Both assays 
were performed on paraffin serial sections (n=4). The total cell number and 
positively stained cell number were counted manually in defined areas of tissues 
under 40X magnification. Statistical analysis of cell counts in serial sections and 
comparison of mutant specimens with controls was performed using one-tailed 
Student’s t test (P values were assigned, with 0.05 being significant). 
 
In Situ Hybridization:  
Radioactive in situ hybridization for Ap2α, Crabp1, and Fgf8 expression was 
performed as described [75, 79-80]. Both sense and antisense 35S-UTP-labeled 
probes were used, and specific signal was observed only with hybridization of the 
antisense probe, in serial sections within at least three independent embryos of 
each genotype. In order to quantitate expression differences, silver grains were 
counted/cell on serial sections. 
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Results 
Generation of neural crest-restricted inducible Smad7 over-expressor 
mouse line   
In order to spatially restrict Smad7 overexpression to the neural crest lineages, 
we used the Wnt1-Cre transgenic driver line (Fig. 5A) [14, 20, 39, 64, 81]. 
Temporal regulation of the onset of Smad7 expression within the neural crest 
was achieved with the inducible reverse tetracycline transactivator (rtTA). The 
Rosa26RrtTA-EGFP mice contain the rtTA with a nuclear localization signal targeted 
into the Rosa26 locus, and a downstream EGFP separated by an IRES 
sequence to ensure efficient EGFP translation (Fig. 5A). The ROSA locus has 
been shown to be expressed in all cell types at all developmental and postnatal 
stages, and its expression is not subject to genetic or environmental changes 
[82].  In the absence of its inducer doxycycline (a derivative of tetracycline), rtTA 
does not recognize its DNA binding sequence, tetO. On the other hand, addition 
of doxycycline allows rtTA to bind the tetO minimal promoter resulting in 
transcription of the myc-Smad7 transgene (Fig. 5A). Furthermore, as the rtTA 
expression module is preceded by a floxed STOP expression cassette, rtTA 
expression is dependent upon Cre/loxP recombinase to remove the loxP-flanked 
STOP expression cassette from within the R26 locus. The R26rtTA-EGFP mice have 
previously been shown to drive robust expression of doxycycline-inducible tet-O 
controlled transgenes [74]. TetO-Smad7 transgenic mice (three separate lines) 
were generated by placing full length Smad7 cDNA under the control of 
heptamerized tetO promoter (Fig. 5A). As there are no commercially-available 
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specific Smad7 antibodies and in order to unequivocally detect transgenic 
Smad7 protein in vivo, we used a myc-tagged Smad7, which has already been 
demonstrated to block TGFβ signaling in vivo in adult transgenic mice [10]. 
Utilizing our Wnt1-Cre/R26rtTA-EGFP/tetO-Smad7 trigenic mice, we can control 
temporal induction of in utero NCC-restricted myc-Smad7 by feeding 
doxycycline-containing food to the pregnant mother (Fig. 5A). 
 
Inducible overexpression of Smad7 in vivo 
In order to verify the “silent but inducible” feature of our trigenic system, we 
placed each of the three individual TetO-Smad7 target mouse lines onto R26rtTA-
EGFP/Wnt1-Cre genetic background to generate Wnt1-Cre/R26rtTA-EGFP/tetO-
Smad7 trigenic mice. Male trigenic offspring were then crossed to homozygous 
female R26rtTA-EGFP mice (fed regular chow) and resultant trigenic embryos 
examined for myc-Smad7 protein and Smad7 mRNA overexpression. To 
simultaneously detect both endogenous and transgenic Smad7 mRNA, forward 
and reverse primers were designed to locate within the Smad7 cDNA transcript. 
For simplicity, the embryos containing all three transgenes (Wnt1-Cre/R26rtTA-
EGFP/tetO-Smad7) are referred to as trigenic embryos, and all littermates with 
other genotypes (Wnt1-Cre, R26rtTA-EGFP, tetO-Smad7, Wnt1-Cre/R26rtTA-EGFP, 
Wnt1-Cre/tetO-Smad7, R26rtTA-EGFP/tetO-Smad7) are referred to as control 
embryos. As expected, normal litter sizes (n=8±2 embryos/litter from 10 litters) 
and trigenic offspring were recovered at expected Mendelian ratios (23.75%) 
when harvested at E14.5 (Table 1). Additionally, western analysis did not detect 
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myc-Smad7 protein expression in normal fed trigenic embryos (Fig. 4). Without 
doxycycline administration to the mother, these embryos develop normally and 
reach adulthood. 
 
When the food was switched from regular to doxycycline-containing food, both 
myc-Smad7 protein induction and elevated Smad7 mRNA expression were 
observed only in trigenic embryos (Fig. 5B, C). Specifically, feeding pregnant 
females doxycycline at E10.5 resulted in both Smad7 mRNA upregulation (8x 
fold) and myc-Smad7 induction in E11.5 trigenic whole embryos but not within 
control (remaining allelic single and double transgenic combinations) littermates 
(Fig. 5B). This rapid induction is consistent with other studies that have shown 
rtTA-driven transgene expression is detectable with adult lungs 6-12 hours after 
doxycycline [83]. Additionally, the relative level of myc-Smad7 induction is 
comparable to the 3x fold elevation in aged skin and 4x fold elevation in some 
tumors [84]. Similarly, mycSmad7 is detected within trigenic E10.5 mutants only 
after being fed doxycycline (Fig. 5C). As similar levels of myc-Smad7 induction 
were observed using all three independent trigenic lines, results from just one 
line are presented to simplify data. Since Smad7 has been shown to negatively 
regulate both TGFβ and BMP signaling in vitro [6], we examined whether myc-
Smad7 induction attenuated both phosphorylated Smad1/5/8 (pSmad1/5/8) and 
phosphorylated Smad2/3 (pSmad2/3) levels in vivo. Western analysis reveals 
that pSmad1/5/8 levels were reduced by 55.5% (P<0.037) and pSmad2 levels 
were reduced by 58.3% (P<0.021) in doxycycline-fed trigenic whole embryos at 
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E10.5 (Fig. 5C, D). Similarly, when just NCC-enriched craniofacial and 1st 
pharyngeal arch tissues were used (Fig. 6), the presence of myc-Smad7 
suppressed both pSmad1/5/8 (by ~72%) and pSmad2 (by ~85%) levels when 
compared to age-matched control tissues. Combined, these data demonstrate 
that transgenic Smad7 expression is tightly controlled in this three-component 
genetic system, and that myc-Smad7 expression is induced rapidly in NCC-
derived tissues by application of doxycycline to the system and the induced myc-
Smad7 represses both TGFβ and BMP signaling in vivo. In addition, when 
doxycycline was administered to wild type pregnant females throughout gestation 
starting at E6, normal litter sizes (n=8 embryos/litter from 6 litters) were 
recovered postnatally, demonstrating that sustained doxycycline does not 
adversely affect in utero morphogenesis. 
 
Overexpression of Smad7 in the neural crest impairs normal craniofacial 
and pharyngeal arches development  
During craniofacial development, cranial NCC migrate ventrolaterally as they 
populate the craniofacial region. The proliferative activity of cranial NCC 
produces the frontonasal process and the discrete swellings that demarcate each 
branchial arch [14]. NCC lineage tracing experiments by crossing Wnt1-Cre with 
Rosa26 reporter [85] mice show Wnt-Cre mediated lacZ gene expression starts 
in the rostral hindbrain around the four somite (E8.0) stage and extends to the 
midbrain, forebrain and caudal hindbrain, and progresses to increasingly caudal 
cardiac and trunk levels by eight somite (E8.5) stage [39]. Thus, Wnt1-Cre allows 
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recombination of floxed STOP R26rtTA-EGFP rtTA expression within the NCC from 
very early stages of its development.   
 
To examine the effects of Smad7 overexpression and to directly test the in vivo 
requirement of regulated TGFβ superfamily signaling during early NCC 
morphogenesis in utero, we fed pregnant trigenic females doxycycline from E7.5, 
a stage that is prior to the onset of Wnt1-Cre expression [39] and NCC 
emigration from the neural tube [12-13, 62-64].  Resultant embryos were 
harvested at E9 to birth. Initially, E9 trigenic embryos are indistinguishable from 
control littermates, but by E10 the trigenics are slightly smaller and exhibit subtle 
craniofacial and pharyngeal arch dysplasia defects (Fig. 7A-C). Specifically, the 
1st pharyngeal arch is hypoplastic and the face/forebrain region is undersized. 
This is more evident at E11.5, as all the trigenic embryos have significantly 
smaller craniofacial regions (n=7/7 trigenics exhibit craniofacial defects) and 
greatly reduced 1st, 2nd and 3rd pharyngeal arches (Fig. 7D-F). By E13.5, the 
trigenic embryos grossly lack identifiable upper and lower jaws (Fig. 7G-I) but are 
otherwise viable. In addition, none of the doxycycline-fed trigenic offspring were 
recovered at birth (n=7 litters). The non-trigenic littermates with remaining allelic 
combinations were phenotypically normal and serve as genetic background, age-
matched and doxycycline-exposure controls (R26rtTA-EGFP/Wnt1-Cre; R26rtTA-
EGFP/tetO-Smad7; R26rtTA-EGFP/R26rtTA-EGFP). Histology revealed that the upper 
and lower jaws were indeed hypoplastic and that the tongue was reduced in size, 
but that Meckel’s cartilage, which forms a template for mandible formation and is 
 25
derived from the cranial NCC [14], is still present (Fig. 8B). This data is 
consistent with the underdevelopment of medial nasal prominences and 
incomplete tongue formation observed in Wnt1-Cre;Smad4loxp/loxp embryos [40-
41]. Histology also revealed that 100% of E13.5 trigenic mutants (n=5) lack the 
choroid plexus that extends into the fourth ventricle, even though the choroid 
plexus extending into the lateral ventricle is present (Fig. 8B). X-Gal staining of 
Wnt1-Cre;R26r brains has shown that recombination of the R26r allele is 
confined to the CNS midbrain, hindbrain and cerebellum & choroid plexus in 4th 
vent /hindbrain [86] and robust TGFβ signaling has been shown to be present 
within the migrating cranial NCC, meninges, and choroid plexus [87]. The 
observed selective loss of the choroid plexus that extends into the fourth ventricle 
is likely due to the restricted Smad7 overexpression within the NCC that 
contribute to this particular choroid plexus.  
 
Induced Smad7 overexpression impairs normal cardiac development  
As trigenic mutants fed doxycycline from E7.5 onwards were not recovered at 
birth and Wnt1-Cre:R26r marked NCC have been shown to be essential for heart 
morphogenesis [13, 64], we examined the effects of overexpression of Smad7 
within NCC lineages in cardiovascular system. Cardiac NCC migrate along the 
3rd, 4th, and 6th pharyngeal arches to colonize the OFT cushions, where they are 
required for septation of the truncus arteriosus into the aorta and pulmonary 
artery [13]. Histology revealed that all trigenic mutants exhibit OFT defects 
(n=11/11 trigenics fed doxycycline at E7.5), specifically a single outlet forming 
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persistent truncus arteriosus (PTA). Besides a failure of OFT separation, the 
ascending aorta in trigenic embryos was retroesophageally located (Fig. 8D) and 
the outlet valve leaflets were abnormally thickened (Fig. 8F) when compared to 
those seen in the control embryos (Fig. 8C, E). Additionally, trigenic embryos 
present accompanying membranous intraventricular septal defects (VSD) (Fig. 
8H). However, trigenic dorsal root ganglia and thymus appeared grossly 
unaffected relative to the overall embryo size (Fig. 8J, L), notwithstanding having 
a NCC contribution [20]. Furthermore, trigenic dorsal root ganglia were normally 
colonized via NCC lineage (Fig. 9). 
 
Neural crest lineage mapping reveals regional deficiencies  
To verify Wnt1-Cre recombination efficiency in trigenics and to determine the 
origin of defects found in craniofacial structures, pharyngeal arches, and the 
heart, trigenic mice NCC were lineage mapped. Earlier studies have shown that 
elements of TGFβ superfamily signaling are required for normal craniofacial and 
cardiac NCC migration. For example, Wnt1-Cre conditional deletion of Smad4 
[40-41, 72-73] and transgenic overexpression of the BMP-antagonist Noggin [15] 
can result in NCC deficiency. Analysis of lacZ stained trigenic mutant embryos 
carrying the R26r reporter showed normal NCC migration and contribution to the 
craniofacial region and dorsal root ganglia, but reduced NCC colonization to the 
OFT. From E10.5-11.5, robust lacZ staining was evident in the frontonasal 
prominence, trigeminal nerve ganglia, 1st, 2nd pharyngeal arches along with facial 
nerve ganglia, and primordium of the 3rd pharyngeal arch in trigenic embryos 
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(Fig. 9A, C, D), similar to that observed in controls (Fig. 9A, B, D). Intriguingly, 
this assay revealed that whereas the NCC populate the craniofacial and 
pharyngeal regions, the 1st, 2nd and facial regions failed to form normally and 
were hypoplastic in trigenics (Fig. 7). However, in E13.5 trigenic embryos there 
were subsequent lacZ-negative areas of frontonasal mesenchyme, suggesting 
that there was a subsequent loss of lacZ-positive cells (Fig. 9N). Similar to the 
cranial NCC, migration of the lacZ-marked cardiac NCC was largely unaffected in 
E10.5 trigenic embryos (Fig. 9A-C), and trunk NCC contribution to the trigenic 
dorsal root ganglia was unchanged when compared to littermate controls (Fig. 
9A, D). However, further analysis of cardiac NCC colonization of the heart shows 
that although a significant number of NCC have populated the pharyngeal arches 
and aortic sac, only a few trigenic NCC colonized the truncal region and there 
was a complete lack of colonization of the more proximal conal cushion region of 
the trigenic truncus arteriosus (Fig. 9G, H, L) when compared to control 
littermates (Fig. 9E, F, K). The foremost difference of cardiac NCC contribution to 
the trigenic OFT embryos could also be seen at later stages (Fig. 9P). The 
difference between the presence of fully penetrant OFT defects and dramatically 
reduced cardiac NCC colonization and unaffected NCC contribution to the dorsal 
root ganglia and normal cranial NCC migration patterns suggests that the cardiac 
NCC population and morphogenesis of the OFT are especially sensitive to 
suppression of TGFβ superfamily signaling. Furthermore, lineage mapping 
established that Smad7-mediated suppression of TGFβ superfamily signaling 
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principally inhibits later cardiac NCC colonization of the OFT rather than early 
NCC emigration and migration from the neural tube. 
 
Trigenic mutants exhibit normal proliferation but increased cell death  
Such dramatic changes in the morphology of the frontonasal and OFT tissues 
could be accomplished via a change in the amount of cell death and/or cell 
proliferation. Cell proliferation assays, using Ki67 to mark cells in all active 
phases of the cell cycle (G1, S, G2, and mitosis) in sectioned E10.5 trigenic 
embryos fed doxycycline from E7.5 onwards, did not detect any decrease in 
facial, 1st pharyngeal arch mesenchyme or OFT cushion cell proliferation index 
(Fig. 10A-C). Total E10.5 1st pharyngeal arch proliferation in trigenic mutants was 
reduced (~675 Ki67 positive cells/arch/10μm section) when compared to age-
matched control embryos (~1,003 Ki67 positive cells/arch/10μm section), due to 
the hypoplastic trigenic phenotype. This was specifically apparent at the base of 
the 1st trigenic arch (Fig. 10B), where the mesenchyme was sparse compared to 
control littermates. However, when proliferating cells were tallied (as a 
percentage of total cells in the 1st pharyngeal arch) to calculate a mitotic index, 
there was no significant difference by this measure (90.9% in controls versus 
91.2% in trigenics). Thus, the defects in mutant embryos were unlikely to be 
caused by reduced NCC proliferation. 
 
In contrast, using the TUNEL assay to mark apoptotic cells, dramatic increases in 
cell death in the E10.5 trigenic facial and pharyngeal arch mesenchyme and 
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within migratory NCC lineages were observed (Fig. 10D-F). Considerable and 
aberrant cell death was localized to the facial primordia and 1st (Fig. 10E), 2nd 
and 3rd pharyngeal arches of trigenic embryos, but not within the OFT cushions 
(Fig. 10M) nor the cardiomyocytes of the heart (Fig. 10M). The sparse 
mesenchyme at the base of the 1st trigenic arch still contained several apoptotic 
cells, but is adjacent to a region of very robust apoptosis (Fig. 10E). When 
TUNEL positive cells were tallied as a percentage of total cells in the 1st arch to 
calculate a cell death index, there was a significant increase in cell death (1.55% 
in controls versus 16.52% in trigenics, P<0.001). To test if these apoptotic cells 
were limited to NCC, we performed X-gal staining on E11.0 trigenic; R26r 
embryos to label NCC and their derivatives followed by TUNEL assay (Fig. 10G). 
As expected, many NCC were positively stained with the TUNEL signal. These 
data are consistent with the dramatic increases in cell death observed in Wnt1-
Cre;Smad4loxp/loxp [40-41, 72-73] and Wnt1-Cre;Alk5loxp/loxp embryos [36], as both 
Smad4 and Alk5 are required for survival of cardiac NCC. Similarly, Wnt1-
Cre;Alk3loxp/loxp embryos exhibit normal NCC migration, but NCC subpopulations 
die immediately after colonization of their target tissues [21]. Intriguingly, loss of 
BMP antagonists (Noggin and Chordin) result in excessive NCC emigration from 
the neural tube that results in elevated NCC-restricted apoptosis [88]. Combined, 
these data reveal that tightly regulated TGFβ superfamily signaling within early 
NCC is required for normal survival of migratory NCC-derived mesenchyme, 
either block of individual TGFβ or BMP pathway effectors or increased BMP 
signaling can both likewise distress NCC survival in vivo. 
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Aortic arch artery remodeling is unaffected 
Given the frequent association of anomalous pharyngeal aortic arch artery (AAA) 
remodeling and pathogenesis of OFT defects [13, 80, 89-90] we used histology 
and  α-smooth muscle actin (αSMA) immunohistochemistry to determine whether 
AAAs were properly patterned in trigenic mutants fed doxycycline from E7.5 
onwards (Fig. 10H-K). This analysis revealed that the trigenic AAAs were well 
formed by E10.5, suggesting that induction of Smad7 in NCC does not disrupt 
initial arch artery formation. However,  αSMA staining of the OFT cushions was 
reduced in E10.5 mutants, and as colonizing cardiac NCC express αSMA [91], 
these results confirm the reduced Wnt1-Cre; R26r lineage mapping data in 
trigenic OFT cushions (Fig. 9). We further examined whether AAAs were 
correctly remodeled E11.5-13.5 and whether αSMA positive NCC-derived cells 
ensheath the remodeled trigenic AAAs (Fig. 10J, K). Both the control and trigenic 
4th and 6th AAAs were intact and exhibit similar intact αSMA expression patterns. 
Despite suppression of TGFβ signaling within NCC lineage, we did not observe 
abnormal regression of AAAs, a defect which was reported in Wnt1-
Cre;Alk2loxp/loxp and Wnt1-Cre;Alk5loxp/loxp embryos [36, 38]. 
 
Localized attenuated TGFβ and BMP signaling  
To further resolve the molecular defects in trigenic mutants caused by NCC-
restricted induction of Smad7, we examined the spatial expression of both 
pSmad1/5/8 and pSmad2 in trigenic and control embryos fed doxycycline from 
E7.5 onwards. Consistent with western data (see Fig. 5C, D and Fig. 6), 
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pSmad1/5/8 and pSmad2 expression was reduced in E10.5 trigenic embryo NCC 
lineages compared to control littermates (Fig. 11). Significantly reduced numbers 
of pSmad1/5/8-positive and pSmad2-positive cells were detected in the 
mesenchyme and ectoderm-derived epithelium of the trigenic frontal facial region 
(Fig. 11B, J) and pharyngeal arches (Fig. 11D, L), and within the aortic sac 
mesenchyme (Fig. 11F, N), but not in the trigenic ventricular 
myocardium/epicardium/endothelium (Fig. 11H, P). Each of the mesenchymal 
sites of reduced pSmad1/5/8 and pSmad2 expression correlate with Wnt1-
Cre;R26r lineage mapped NCC (Fig. 9) [14, 20], indicating that both TGFβ and 
BMP signaling were significantly attenuated within NCC in vivo by 
overexpression of myc-Smad7. These immunohistochemical data are consistent 
with the significantly reduced pSmad levels detected via whole body (Fig. 5) and 
NCC-enriched western blotting (Fig. 6).  
 
Altered gene expression in pharyngeal arches in trigenic embryos 
To investigate the signaling mechanism of Smad7 overexpression in regulating 
epithelial-mesenchymal interactions, we examined expression patterns of genes 
that express in the early neural tube and migratory NCC and genes that are 
critical during early mandible development.  We examined expression of the 
Crapb1 and Ap2α NCC markers, as well as Fgf8 expression in E10.5-13.5 
trigenic and control embryos fed doxycycline from E7.5 onwards (Fig. 12). Both 
Crabp1 and Ap2α transcription factors are retinoic acid responsive genes that are 
expressed in migrating NCC [79-80]. In developmentally older embryos, Ap2α is 
 32
still expressed within migratory NCC but is also expressed robustly within the 
ectoderm [92]. Fgf8 encodes a signaling growth factor molecule expressed in the 
epithelia of pharyngeal arches, and is required for normal growth of pharyngeal 
arches and remodeling of OFT [93]. Significantly, expression of Crabp1 (Fig. 
12B) and Ap2α were visibly reduced (but not eliminated) from their expression 
domains within E10.5 trigenic migratory cardiac NCC, whereas expression of 
CrabpI was not noticeably affected within non-NCC derived body wall. Ap2α was 
also reduced within trigenic facial mesenchyme, but that most likely reflected 
apoptotic loss of cranial NCC. Intriguingly, while ectodermal Ap2α expression 
appeared comparable between control and trigenic littermates, trigenic 1st arch 
mesenchyme Ap2α expression was increased compared to control mesenchyme 
(Fig. 12C, D). Correspondingly, Fgf8 was specifically elevated within the trigenic 
1st pharyngeal arch and facial ectodermal lineages (Fig. 12F). Counting of silver 
grains/cell revealed a ~4x increase in Fgf8 expression in trigenic (87 +/-11 
grains/cell; n=3 embryos, five 10μm sections/embryo) vs. control (22 +/-8 
grains/cell; n=3 embryos, five 10μm sections/embryo) 1st arch ectoderm. 
Collectively, these results indicate that suppression of TGFβ superfamily 
signaling within the cranial and cardiac NCC disrupted not only gene expression 
in distinct NCC populations but also normal developmental processes in 
neighboring cell populations. Thus, bystander effects upon neighboring epithelial 
TGFβ superfamily signaling may augment the subsequent hypoplasia of these 
structures and contribute to the overall pathogenesis of the severe malformations 
in trigenic mutant embryos. 
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Overexpression of Smad7 in the neural crest following OFT colonization 
also results in abnormal heart development  
To examine the effects of Smad7 overexpression within post-migratory NCC 
following colonization of their target tissues, we fed pregnant trigenic females 
doxycycline from E10 onwards. Our initial characterization of the trigenic system 
revealed that feeding pregnant females doxycycline at E10.5 resulted in both 
Smad7 mRNA upregulation and myc-Smad7 induction by E11.5 in only trigenic 
but not control littermates (see Fig. 5). Grossly, E14.5 trigenic fetuses were 
indistinguishable from control littermates, but histology revealed that 100% of the 
E14.5 trigenic mutants exhibit membranous VSD (n=7/7 trigenics exhibit heart 
defects; Fig. 13D) that persisted until birth (n=3/3 trigenics). Additionally, 
although the trigenic OFT was divided and separate aorta and pulmonary arteries 
exit their respective right and left ventricles, there was a significantly dilated 
outflow lumen and possibly reduced endocardial cushion cells (Fig. 13B). Further 
examination of the dorsal root ganglia, thymus and craniofacial regions did not 
reveal any other histological defects (not shown). Wnt1-Cre;R26r lineage 
mapping revealed that regular numbers of NCC colonize the trigenic OFT and 
aorticopulmonary septum at the appropriate developmental stage, and that they 
survive until at least E13.5 (Fig. 13F) following post-migratory Smad7 
overexpression. Additionally, histology revealed that the OFT was fully divided 
and that the trigenic valves were normal (Fig. 13F). Significantly, 
myocardialization of the cushions occurs (Fig. 13G, H) and there are similar 
levels of apoptosis (Fig. 13I, J) in both trigenic and control littermates. This is 
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significant as it has been proposed that the relatively small population of cardiac 
NCC cells that migrate into the proximal cushions are required to die to promote 
myocardialization [94].  
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Discussion 
The physiological consequences of postnatal Smad7 dysregulation is 
demonstrated by the finding that SMAD7 is upregulated in a number of 
pathological conditions in patients, including development of malignancy [95-96], 
scleroderma [97], and chronic inflammatory bowel diseases [98]. Smad7 has also 
recently been shown to be required for embryogenesis as the majority of Smad7 
knockout mouse embryos die in utero due to multiple defects in cardiovascular 
development, including VSD and OFT malformations [99]. Indeed, endogenous 
Smad7 mRNA is transiently activated pre-implantation, then is re-expressed 
widely post-gastrulation [100]. In E10 and E12.5 embryos, Smad7 mRNA is 
widespread outside the developing central nervous system, including the NCC-
derived mandibular and medial nasal processes, developing pharyngeal arches, 
OFT cushions of the heart, adrenal primordium and trigeminal ganglion [55, 100]. 
Transgenic reporter and Cre/loxP lineage mapping using a partial Smad7 
promoter have also confirmed the robust expression of Smad7 mRNA within the 
craniofacial, pharyngeal arch and cardiovascular system [75, 101]. However, the 
role of Smad7 within the NCC lineage and specifically the effects of mis-
regulation of Smad7 and overexpression in utero remain unknown. 
 
We hypothesized that in vivo misexpression of a potent TGFβ signaling inhibitor 
like Smad7 would generate severe NCC cell hypoplasia and resultant 
neurocrestopathies. Our data provide compelling genetic evidence demonstrating 
that forced expression of Smad7 within NCC is detrimental to development of 
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NCC and their derivatives. Moreover, we showed that levels of both TGFβ and 
BMP phosphorylated R-Smads were reduced in the NCC expressing myc-
Smad7. Since TGFβ superfamily signaling is known to increase production of 
phosphorylated forms of R-Smad proteins, our data provide good evidence that 
TGFβ signaling in vivo is impaired by myc-Smad7 induction in NCC. The 
spectrum of trigenic phenotypes fit well with previous studies reporting 
craniofacial, pharyngeal, cardiac defects and in utero lethality within NCC 
restricted Wnt1-Cre;Smad4loxp/loxp embryo mutants  [40-41, 72-73]. Thus, 
combined these data strongly suggest that altered NCC TGFβ superfamily 
signaling, either via targeted deletion of Smad4 or upregulation of Smad7 can 
both play pathogenic roles that result in neurocrestopathies.  
 
Although members of the WNT family have been shown to specify NCC from 
early dorsal neuroepithelial cells [102-103] and Wnt/β-Catenin signal activation 
plays an instructive role in specification of NCC sensory fate [104], the molecular 
mechanisms underlying the determination, pathway-dependent control and 
morphogenesis of the diversity of NCC fates remains far from clear. Some 
alternative NCC fates have been shown to be instructively promoted by TGFβ 
superfamily members [102, 105]. For example, Bmp2 causes cloned NCC to 
form autonomic neurons and can also induce some smooth muscle 
differentiation, while TGFβ1 exclusively promotes smooth muscle differentiation 
[105]. Surprisingly, although our lineage analysis and immunohistochemical 
assays revealed robust NCC death within trigenic embryos fed doxycycline from 
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E7.5 onwards, subsequent NCC colonization of the trigenic dorsal root ganglia, 
trigeminal ganglion, thymus and αSMA-positive NCC-derived subpopulation that 
ensheath the remodeling trigenic AAA which give rise to the great vessels exiting 
the heart were all unaffected (Fig. 9, 10). Thus, Smad7 induction appears to 
aberrantly affect specific subpopulations of NCC, independent of where they 
originate from, when they initiate migration or even how far they are required to 
migrate prior to target tissue colonization. Indeed, forced expression of Smad7 
within pancreatic beta cells [106] and human umbilical cord blood cells [107] has 
similarly been shown to inhibit differentiated cell formation and suppression of 
TGFβ signaling alters cell fate decisions. 
 
Craniofacial and cardiac defects thought to arise principally from perturbation of 
NCC morphogenesis are prominent features of DiGeorge syndrome 
(DGS)/velocardiofacial syndrome (VCFS), as well as Noonan syndrome (NS) 
[108-109]. While NS is caused by a gain-of-function mutation in SHP2 [109], 
DGS/VCFS is the result of a recurrent deletion in chromosome 22q11 [110]. 
DGS/VCFS is the most common micro-deletion syndrome in patients [108], but 
not all DGS/VCFS patients have the 22q11 deletion [111-112]. Additionally, 
several modifiers of the DGS/VCFS have been identified in patients and modeled 
using mouse transgenics, including VEGF [90], FGF8 [108] and CHD7 [113]. 
Although the microdeletion of 22q11 encompasses ~30 genes, including Arc105, 
Tbx1 and Crk1, it does not include any of the TGFβ superfamily receptors or 
ligands. Thus, gene products eliminated by 22q11 deletions may functionally 
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interact with TGFβ signaling within the NCC lineage. For instance, Arc105 has 
been shown to modulate TGFβ signaling within embryos [114], and both Tbx1 
[113] and Crkl [30] can directly regulate TGFβ signaling within murine NCC via 
modulating R-Smad phosphorylation and altering the ability of R-Smads to bind 
Smad4 [115]. These findings imply that the common developmental 
abnormalities observed in DGS/VCFS and NS patients may arise from 
perturbation of the same pathway. Although the reduced expression levels of 
Ap2α and Crabp1 mRNA are to be expected (Fig. 12) given the observed 
elevation of NCC death (Fig. 10), our molecular marker analysis did reveal an 
unexpected finding. One particularly significant discovery is that Fgf8 levels are 
elevated within the epithelia of the trigenic pharyngeal arches, as FGF8 is a 
known modifier of DGS/VCFS and FGF8 signaling is mediated by Crkl [108]. 
Functions of these genes have been implicated in mediating interactions 
between NCC and their neighboring cells in facial primordia and pharyngeal 
arches, and subsequent organogenesis [116]. Combined, these data indicate 
that suppression of TGFβ signaling within the cranial and cardiac NCC disrupts 
not only distinct NCC gene expression, but also normal developmental processes 
in neighboring cell populations. In order to find the common downstream 
effectors, detailed analysis of the resultant gene expression profile changes 
within isolated trigenic NCC subpopulations will be required to identify which 
NCC-restricted gene pathways are altered in response to suppressed TGFβ 
signaling. 
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The spectrum of cardiac defects caused by Smad7 induction in early NCC 
resembles those associated with cardiac NCC ablation in avian embryos, in 
which both anomalous AAA remodeling and lack of OFT septation with 
concomitant VSDs are observed [117]. Cardiac NCC normally migrate to the 
OFT region via the 3rd, 4th and 6th pharyngeal arches to form the two-pronged 
cushions in the truncal region of the OFT where they contribute to the septation 
of aorta and pulmonary outlets [65]. However, not all cardiac NCC colonize the 
OFT cushions, as a subpopulation remains in the caudal pharyngeal arches and 
differentiates in a smooth muscle layer enveloping the 4th and 6th arch arteries 
[20, 118]. Surprisingly, despite extensive NCC death and reduced Wnt1-
Cre;R26r reporter expression within trigenic mutants that exhibit severe OFT 
septation and VSD defects, both smooth muscle actin expression and normal 
AAA remodeling were observed (Fig. 9, 10). This is consistent with the 
phenotypes reported in Wnt1-Cre;Smad4loxp/loxp and Wnt1-Cre;Tgfbr2loxp/loxp 
mutants [34, 40-41, 72-73], Thus, OFT septation defects appear to be a common 
feature of all mouse models in which TGFβ signaling is impaired in NCC, 
indicating a central role for TGFβ superfamily signaling within NCC during 
cardiac development. Although it is possible for embryos to exhibit OFT septation 
defects without AAA abnormalities and it is possible to have AAA defects without 
OFT septation defects [118], it remains unclear why suppression of TGFβ 
signaling within the cardiac NCC subpopulation predominantly results in only 
OFT septation defects. It has been proposed that TGFβ signaling may not be 
required for specification of a smooth muscle fate because this is the default 
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pathway or that TGFβ signaling within cardiac NCC acts as a local morphogenic 
factor rather than as an instructural cue for cell lineage specification or smooth 
muscle differentiation [34]. Our trigenic data would support these conclusions 
and additionally infer that TGFβ signaling in cardiac NCC within the pharyngeal 
arches is required to provide the stimulus for subsequent NCC colonization of the 
OFT itself and for survival of this colonizing OFT subpopulation. This conclusion 
is further supported by our significant finding that later induction of Smad7 in 
NCC that have already reached the pharyngeal arches and OFT also results in 
OFT anomalies and VSD (Fig. 13). Since Smad7 blocks multiple receptor-
activated TGFβ signaling pathways, our work has not yet revealed roles of 
individual receptor-mediated TGFβ pathways that are responsible for maintaining 
this colonizing OFT NCC subpopulation.  
 
Elucidating the molecular pathways and mechanisms regulating the fate of the 
cranial and cardiac NCC subpopulations is fundamental to our understanding of 
the pathogenesis of numerous congenital syndromes. In addition to stimulatory 
factors, migrating NCC encounter environments rich in inhibitors that may 
counteract signaling molecules such as WNTs, BMPs and TGFβ. Our Smad7 
inhibitory NCC-restricted studies reinforce the notion that TGFβ signaling is 
dispensable for NCC formation and emigration but plays a critical role during 
craniofacial and cardiac NCC morphogenesis and colonization of target tissues. 
We observed a severe reduction of NCC pSmad2 and pSmad1/5/8 expression, 
resulting in suppression of the temporal and spatial specification of TGFβ 
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signaling and subsequent loss of craniofacial and OFT cushion NCC in trigenic 
Smad7 embryos. Moreover, Smad7 overexpression within post-migratory cardiac 
NCC also resulted in cardiac defects, suggested that TGFβ signaling plays 
multiple roles at multiple times, even in the same NCC subpopulation. Although 
there is a paucity of data regarding the function of post-migratory NCC within the 
heart itself, it has been shown that NCC-specific N-cadherin, RhoA and Cx43 
expression are each required for normal OFT morphogenesis, cell shape, 
alignment and cell-cell communication. Wnt1-Cre;N-cadherin mutant NCC are 
unable to elongate and align properly along the midline and remained rounded 
with limited contact with their neighbors within mutant OFTs [119]. Activation of 
RhoA is required for NCC contact inhibition of locomotion in vivo to control NCC 
directional migration [120]. Cx43 mediates modulation of polarized cell 
movement and the directional migration of cardiac NCC [121]. Significantly, N-
cadherin, RhoA and Cx43 are all known to be responsive to TGFβ-signaling [2], 
thus these data suggest that further studies are required to understand the link 
between lineage commitment and the many changes in cushion cell shape, cell-
matrix adhesion, and cell-cell adhesion that occur within the OFT itself and 
during interventricular septal morphogenesis, and how suppression of TGFβ 
superfamily signaling may aberrantly affect one or more of these processes. 
Perhaps inhibitors of TGFβ inhibitors are required to titrate or delay responses as 
NCC differentiate along particular pathways, and that Smad7 overexpression 
prevents endocardial cushion differentiation resulting in defective septation. 
Taken together, these results demonstrate that fine-tuning of TGFβ signaling via 
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proteins including Smad7 is crucial for normal development. We speculate that 
this method for conditional myc-Smad7 expression may be useful for elucidating 
further TGFβ roles in other organs and tissues and addressing the biological 
significance of the concerted action between growth and transcription factors in 
regulating normal development and disease. 
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Litters Embryos from each litter Trigenic embryos 
1 7 3 
2 5 2 
3 10 1 
4 10 2 
5 7 2 
6 9 2 
7 7 1 
8 6 1 
9 11 3 
10 8 1 
 Total: 80 Total: 19 (23.75%) 
 
Table 1.  Embryos harvested at E14.5 fed regular food.  
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Figure 4. No mycSmad7 was detected by western blot in E14.5 embryos fed 
with regular food. -, mycSmad7 negative sample; +, mycSmad7 positive 
sample; 122, 123, 125 are trigenic embryos based on PCR; 124, 126, 127, 128 
are control embryos based on PCR. 
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Figure 5. Evaluation of the trigenic Cre/loxP-dependent, tetracycline 
inducible transgenic system. (A) Schematic illustrating operation of the trigenic 
system. The R26rtTA-EGFP knockin mice will only express the rtTA from the Rosa26 
locus upon Cre-mediated recombination [74]. Wnt1-Cre transgenic mice have 
been shown to label almost all NCC, including the cardiac and craniofacial NCC 
lineages [14, 20]. In the tetO-Smad7 transgenic mice, myc-Smad7 full length 
cDNA (myc tag is blue box 5’ of Smad7 cDNA) is under the control of 
heptamerized tetOn promoter, but Smad7 is not expressed until both the 
transactivator (rtTA) and inducer (doxycycline) are present within the same cell. 
Although all three transgenes are individually silent within the compound trigenic 
mice, myc-tagged Smad7 can be specifically induced within Cre-positive neural 
crest lineages upon doxycycline feeding. Thus, the spatiotemporal timing of myc-
tagged Smad7 expression is determined by the timing of doxycycline addition 
and positionally by the expression of Cre recombinase. (B) RT-PCR analysis 
reveals that Smad7 mRNA expression is upregulated ~10 fold in trigenic E10.5 
embryos fed doxycycline at E7.5 compared to control embryo expression of 
endogenous Smad7 (n= 4 embryos of each genotype). Loading was normalized 
using GAPDH housekeeping control. (C, D) Western analysis verifies that myc-
Smad7 is only expressed within trigenic E10.5 embryos fed doxycycline at E7.5, 
and is absent from littermate control embryos (n=3). The presence of myc- 
Smad7 suppressed both pSmad1/5/8 and pSmad2 levels relative to total Smad1 
and pSmad2/3 levels when compared to age-matched control littermates, 
indicating overexpression  of Smad7 attenuates both BMP and TGFβ signaling 
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by ~55% (D). Loading was normalized using tubulin housekeeping control. 
Abbreviations: tri, trigenic Wnt1-Cre/RosartTA-EGFP/tetO-Smad7 embryos; con, 
control embryos; *, significant change.  
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Figure 6. Western analysis of NCC-enriched craniofacial tissues. Both E10.5 
control (con) and Smad7 trigenic (tri) microdissected frontonasal regions 
(including 1st pharyngeal arch) fed doxycycline at E7.5, were examined via 
Western analysis. Note that myc-Smad7 is only expressed within pooled (n=4) 
doxycycline-fed trigenic E10.5 tissues, but is absent from pooled control (n=4) 
samples. Moreover, in tissues known to be mostly populated by NCC, 
densitometry revealed that the presence of myc-Smad7 suppressed both 
pSmad1/5/8 (by ~72%) and pSmad2 (by ~85%) levels relative to total Smad1 
and pSmad2/3 levels when compared to age-matched controls. Abbreviations: 
tri, trigenic Wnt1-Cre/RosartTA-EGFP/tetO-Smad7 embryos; con, control embryos; *, 
significant change. 
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Figure 7. Early Smad7 induction within the neural crest lineage suppresses 
normal craniofacial and pharyngeal arch development. (A-C) E10.0 control 
and trigenic (right embryo in A) whole embryos fed doxycycline at E7.5 appear 
grossly similar except smaller facial processes, but higher magnification reveals 
that the mandibular component of the E10.0 trigenic mutant 1st pharyngeal arch 
is undersized and the oropharyngeal region below the nasal process is enlarged 
(indicated by * in C) when compared to age-matched control (B). (D-F) E11.5 
control and trigenic (right embryo in D) whole embryos. Note trigenic 1st and 2nd 
arches are dramatically underdeveloped and the facial processes are hypoplastic 
(F) when compared to controls (E), but the size of the trigenic heart appears 
unaffected. (G-I) E13.5 control and trigenic (right embryo) whole embryos fed 
doxycycline at E7.5. Note in isolated heads (severed immediately below lower 
jaw) both the upper and lower jaws of the trigenic mutant are severely 
hypoplastic and largely absent (I) when compared to control littermates (H). 
Abbreviations: 1, first pharyngeal arch; 2, second pharyngeal arch; a, atrium; v, 
ventricle; lv, left ventricle; e, eye. Bar in A=0.1mm; B, C=0.05mm. [Paige L. 
Snider contributed to this figure].  
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Figure 8. Histological examination of E13.5 Smad7 trigenic phenotypes fed 
doxycycline at E7.5. (A, B) Control and trigenic littermate cranial regions 
sectioned sagittally and stained with H&E. Note the absent ventral extremity of 
the lower jaw and lip, hypoplastic tongue, absent primary palate, and absent 
upper jaw and lip in trigenic mutant (* in B). However, Meckel’s cartilage is still 
present in the mutant (yellow arrowhead). While the choroid plexus (cp) 
extending into the trigenic lateral ventricle is present, the choroid plexus 
differentiating from the roof of the fourth ventricle is absent (arrow in B). (C-H) 
Low power images of serial sagittal sections through control (C, E, G) and 
trigenic (D, F, H) cardiothoracic regions at the level of the OFT and high power 
images of the interventricular septum (G, H). While the control has separate 
ascending aorta and pulmonary trunk vessels (C, E), the trigenic mutant outflow 
tract has failed to separate and remains as a single outlet (PTA; E) and the single 
OFT is retroesophageally located in the trigenic embryo (arrow in D). 
Additionally, the trigenic embryo exhibits accompanying interventricular septal 
defects (H). (I-L) Higher power images of transverse sections reveal that both the 
trigenic dorsal root ganglia (J) and thymus (L) are histologically normal when 
compared to control littermates (I, K). Abbreviations: t, tongue; nt, neural tube; 
PTA, Persistent Truncus Arteriosus; VSD, Ventricular Septum Defect; sep, 
septum; rv, right ventricle; lv, left ventricle; la, left ventricle; Ao, aortic trunk; dAo, 
descending aorta; p, pulmonary trunk; drg, dorsal root ganglia; thy, thymus; X, 
vagal X trunk. Bars in I, J=10μm. [Paige L. Snider and Mica Gosnell contributed 
to this figure]. 
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Figure 9. NCC develop in Smad7 trigenic mutant embryos fed doxycycline 
at E7.5. To lineage map both the trigenic and control NCC populations, R26r 
lacZ reporter mice were crossed with Smad7 trigenic to enable us to visualize 
NCC migration and colonization of the craniofacial and OFT regions. (A-C) E10 
whole mount lacZ staining of trigenic and control littermates revealed that initial 
NCC migration was largely unaffected within the trigenic (right embryo in A) 
cranial, cardiac and trunk regions when compared to control littermates. Robust 
lacZ expression is evident in trigenic frontonasal prominence, trigeminal nerve 
ganglia, hypoplastic 1st, 2nd and 3rd arches and within the facial nerve ganglia, 
and primordium of the 3rd pharyngeal arch. Similarly, lacZ-marked NCC are 
present within the cardiac 4/6th arch region and the DRGs (*) in trigenic mutants. 
(D-J) LacZ stained E11.5 trigenic and control littermate whole embryos (D); 
isolated control (E, F) and trigenic (G, H) hearts viewed frontally (E, G) and from 
the right (F, H); and higher power views of control (I) and trigenic (J) craniofacial 
regions. Note there is a deficiency of NCC-derived Schwann cells within SNS of 
trigenic forelimb, but trunk NCC migration is unaltered. (E-H) Higher power views 
of isolated hearts clearly show that Smad7 trigenic NCC reach the pharyngeal 
arches and aortic sac region, that a few mutant NCC can enter the OFT truncal 
region but that there are no lacZ stained NCC within the trigenic OFT conal 
region (* in H) when compared to controls (E, F). Similarly, although trigenic NCC 
do colonize the hypoplastic craniofacial regions, there are reduced numbers of 
lacZ positive cells, particularly evident within the frontal nasal process and 3rd, 4th 
and 6th pharyngeal arches (arrow in J). (K, L) Sections through OFT from distal 
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to proximal in E11.5 control (K, K’, K”) and trigenic embryos (L, L’, L”). Histology 
confirms a lack of trigenic NCC colonizing the OFT, that there are fewer cells 
within the conal cushions and that the mutant NCC are not found in ectopic 
locations within the adjacent myocardial cuff (arrow in L’) or overlying 
endothelium. (M-P) LacZ stained E13.5 control (M, O) and trigenic littermate 
whole embryos and isolated hearts viewed frontally. Note the absent lacZ NCC 
within the trigenic upper and lower craniofacial regions (arrow in N) and the 
absence of lacZ positive NCC within the trigenic OFT (arrow in P). Abbreviations: 
fl, forelimb; lv, left ventricle; a, atria; oft, outflow tract; ec, endocardial cushions; 
rv, right ventricle; ra, right atria; e, eye. Bars in I, J=0.2mm. [Paige L. Snider, 
Sunyong Tang and Mica Gosnell contributed to this figure]. 
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Figure 10. Elevated cell death of NCC in Smad7 trigenic mutants fed 
doxycycline at E7.5. (A-C) Ki67 staining at E10.5 on sagittal sections reveals 
equivalent levels of cell proliferation (n=4) within the trigenic 1st (B) and 2nd (not 
shown) pharyngeal arches when compared to controls (A). (D-F, L, M) In 
contrast, TUNEL staining at E10.5 (n=4) demonstrates a notable increase in cell 
death in trigenic mutants within the mandibular component of the 1st arch (arrow 
in E) compared to controls (D), but not in the OFT cushions (M) nor in the 
myocardium (M). (G) TUNEL staining (brown) of lacZ-stained E11 R26r trigenic 
embryo (transverse section of right pharyngeal/OFT region lying on left hand 
side) demonstrates that apoptotic cells (arrows) are of NCC (blue) origin. Note 
that trigenic non-NCC derived core arch mesenchyme (indicated by yellow line), 
cephalic mesenchyme (cm) and body wall (bw) are largely devoid of apoptotic 
cells. However, as expected the pharyngeal pouch endoderm exhibits robust 
apoptosis (*). (H-K) α-SMA staining showed that NCC differentiation into smooth 
muscle within the E10.5 trigenic (I) aortic sac was comparable to controls (H), 
that α-SMA staining (brown) within the trigenic OFT cushions was reduced (*) 
and that transient cardiomyocyte expression of α-SMA was unaffected in both 
control and trigenic mutant hearts. Similarly, NCC-derived smooth muscle 
colonization of the control (J) and trigenic (K) 6th aortic arch arteries (arrows) was 
comparable at E13.5. Abbreviations: as, aortic sac; a, atria; h, heart; myo, 
myocardium; oft, outflow tract; PTA, Persistent Truncus Arteriosus. 
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Figure 11. NCC-restricted Smad7 overexpression results in decreased 
TGFβ and BMP signaling. (A-H) pSmad2 immunohistochemistry on E10.5 
sagittal sections demonstrated that TGFβ signaling is reduced in both 
craniofacial and cardiovascular tissues colonized by NCC within trigenic (B,D,F) 
embryos fed doxycycline at E7.5 when compared to control littermates (A,C,E) 
but that pSmad2 expression is unaffected within control (G) and trigenic (H) 
ventricles. Note that pSmad2-positive cells (brown staining) are significantly 
reduced within the trigenic mesenchymal nasal process and the overlying 
epithelium (* in B), as well as within the 1st pharyngeal arch mesenchyme and 
overlying epithelium (* in D). Similarly, there is almost a complete absence of 
pSmad2-positive NCC around the trigenic aortic sac and within the truncal region 
of the OFT (F). (I-P) pSmad1/5/8 immunohistochemistry on E10.5 sagittal 
sections similarly demonstrated that Bmp signaling is attenuated in both 
craniofacial and cardiovascular tissues colonized by NCC within trigenic (J, L, N) 
embryos fed doxycycline at E7.5, when compared to control littermates (I, K, M) 
but that pSmad1 expression (brown staining) is unaffected within control (O) and 
trigenic (P) ventricles to which NCC do not contribute. Sections were 
counterstained with 0.05% toluidine blue. Abbreviations: mes, mesenchyme of 1st 
arch; as, aortic sac. Bars in B, G, J, O=10μm. [Mica Gosnell contributed to this 
figure]. 
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Figure 12. Molecular marker analysis of E10.5 trigenic mutant phenotype. 
Radioactive in situ hybridization detection of Crabp1 (A, B), Ap2α (C, D) and Fgf8 
(E, F) mRNA in control (A, C, E) and trigenic mutants (B, D, F) fed doxycycline at 
E7.5. (A, B) Transverse sections through the OFT region of trigenic mutants 
reveal that Crabp1 expression is reduced within the pharyngeal arch region 
around the foregut (indicated by * in B) and along the NCC migration routes 
around the dorsal aorta, but not within the thoracic body wall (arrows). (C, D) 
Sagittal sections of trigenic mutants indicate that Ap2α expression is reduced in 
the trigenic nasal process (* in D) and that Ap2α is ectopically expressed within 
the mesenchyme of 1st arch (arrow) when compared to control littermate (C). (E, 
F) Sagittal sections of trigenic mutants also reveal that Fgf8 expression is 
upregulated within the epithelium overlying the nasal process (* in F) and 1st arch 
mesenchyme (arrow in F) but that trigenic Fgf8 expression within the neural 
epithelial layer of the optic cup is comparable with control expression levels. 
Abbreviations: da, dorsal aorta; oft, outflow tract; e, eye. [Jian Wang contributed 
to this figure]. 
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Figure 13. Analysis of E14.5 Smad7 trigenic heart phenotypes fed 
doxycycline at E10. (A, B) Control and trigenic littermate OFT regions sectioned 
transversely and stained with H&E. Note both the control (A) and trigenic (B) left 
and right lobes of the thymic rudiment are normally situated and unaffected by 
myc-Smad7 induction (n=4 trigenic and 5 control fetuses). However, the trigenic 
OFT truncal endocardial cushions are smaller and the lumen of the outlet of the 
right ventricle is abnormally dilated (arrow in B). (C, D) Additionally, the trigenic 
embryo exhibits an isolated VSD (arrow in D) but the control heart is separated 
normally (C). (E, F) To lineage map both the trigenic and control post-migratory 
NCC populations, R26r lacZ reporter mice were crossed with Smad7 trigenic 
mice. Transverse sections through the E13.5 OFT revealed similar patterns of 
cardiac NCC (blue) within the aorticopulmonary septum (not shown) and valves 
in both control (E) and trigenic (F) littermates. Note that trigenic cardiac NCC are 
still present and that the valves are normal. (G, H) α-SMA staining showed that 
myocardialization occurs normally in both E13.5 control (G) and trigenic (H) 
hearts. Note active myocardialization of endocardial cushions at base of the 
OFTs (indicated by *). (I, J) TUNEL staining (brown) revealed that both the 
patterns and level of apoptosis (indicated by arrows) are grossly similar in E13.5 
control (I) and trigenic (J) OFTs. Abbreviations: thy, thymic lobes; rv, right 
ventricle. [Paige L. Snider, Sunyong Tang and Mica Gosnell contributed to this 
figure]. 
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Chapter III:  Regulation of TGFβ superfamily signaling is critical during 
sympathetic ganglia and craniofacial neural crest differentiation but is 
dispensable post-differentiation 
 
Abstract 
TGFβ superfamily signaling plays an essential role in neural crest cell (NCC) 
development. We are using a doxycycline inducible 3.9 kb Periostin-Cre (Peri-
Cre) driven trigenic system to express Smad7, an inhibitor of TGFβ superfamily 
signaling, to study the role of TGFβ superfamily signaling in post-migratory NCC.  
Overexpression of Smad7 in post-migratory NCC marked by Peri-Cre resulted in 
hypoplastic 1st and 2nd pharyngeal arches, loss of frontofacial tissues, blood 
pooling in the blood vessels, and mid-gestational lethality. Cellular analysis 
demonstrated that the hypoplastic tissues were due to dramatically increased 
apoptosis in the 1st and 2nd pharyngeal arches and frontofacial region. Molecular 
analysis showed that overexpression of Smad7 suppressed both BMP and TGFβ 
signaling, and resulted in increased phospho-p38 levels in frontofacial tissues, 
which might be the cause of elevated apoptosis observed in these regions. The 
sympathetic ganglia were also hypoplastic, and they produced significantly less 
tyrosine hydroxylase, which resulted in the mid-gestational lethality. 
Overexpression of Smad7 in sympathetic ganglia after they have differentiated, 
however, did not result in embryonic lethality. Taken together, our data 
demonstrated that TGFβ superfamily signaling in the sympathetic ganglia is 
critical for normal differentiation but dispensable for their survival.  
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Introduction 
Neural crest cells (NCC) are a transient population of cells formed during early 
vertebrate embryonic development. After neurulation, NCC undergo epithelial to 
mesenchymal transformation, delaminate and migrate along defined pathways to 
contribute to the formation of a variety target tissues and organs [12-13].  NCC 
are multipotent and are known to be dependent on cues from the extracellular 
environment, such as sonic hedgehog, WNTs, BMPs and TGFβs to differentiate 
to defined cell types [11].  
 
TGFβ superfamily consists of more than 30 ligand proteins [1] including TGFβ 
isoforms, activins, BMPs and other ligands. Members of this family represent 
structurally similar, but functionally diverse growth factors which play diverse 
biological roles during cell proliferation, differentiation, apoptosis and many other 
tissue remodeling processes, including early embryogenesis and heart 
morphogenesis. The signaling of TGFβ superfamily initiates by binding of ligands 
to the type II receptor, which then recruits type I receptor and activates it [2]. 
Activated type I receptor then phosphorylates regulatory (R)-Smads (Smad1, 2, 
3, 5 or 8), which subsequently form a complex with the co-Smad, Smad4. The 
complex then translocates into nucleus to regulate gene transcription [66-68]. In 
contrast to the R-Smads, the inhibitory (I)-Smads (Smad6 and 7) negatively 
regulate TGFβ superfamily signaling in vitro. While Smad6 negatively regulates 
BMP signaling [3-4], Smad7 negatively regulates both TGFβ and BMP signaling 
[4-8]. 
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Many TGFβ superfamily signaling components have been manipulated in vivo in 
the developing neural crest. Inactivation of genes encoding TGFβ2 and TGFβ3 in 
mice resulted in severe craniofacial malformations, while BMP overexpression or 
blocking BMP by its inhibitor Noggin in developing chicken affected sympathetic 
ganglia formation [28-31]. With respect to receptors for TGFβ family factors, 
TGFβ type II receptor (Tgbfr2) and TGFβ type I receptor (Alk5) inactivation in the 
neural crest caused extensive craniofacial defects, such as cleft palate, and 
cardiovascular malformations including aortic arch patterning deficiencies, 
persistent truncus arteriosus, and septal defects [30, 32-36]. Similar defects 
resulted from neural crest specific deletion of receptors mediating BMP 
responses [37-39]. In addition, ablation of Smad4 or overexpression of Smad7 in 
neural crest lineages led to massive cell death and thus malformations in both 
craniofacial and cardiovascular neural crest derivatives [40-42] as well as 
reduced size and altered patterning of trigeminal ganglia [41]. 
 
However, all of the above investigations were manipulating TGFβ superfamily 
signaling in pre-migratory NCC. Almost nothing is known about the role of TGFβ 
signaling in post-migratory NCC after they have reached their target tissues and 
organs. In this research, we crossed Peri-Cre transgenic mouse with our 
doxycycline induced overexpression of Smad7 mouse model [42] to over-express 
Smad7 in a subpopulation of post-migratory NCC only after they have reached 
their target tissues and organs.   
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The results presented here showed that overexpression of Smad7 in early stage 
post-migratory NCC marked by Peri-Cre resulted in hypoplastic 1st and 2nd 
pharyngeal arches, loss of frontofacial tissues, blood pooling in the blood 
vessels, and mid-gestational lethality. The hypoplastic tissues were due to 
dramatically increased apoptosis in the 1st and 2nd pharyngeal arches and 
frontofacial region. Molecular analysis showed that overexpression of Smad7 
suppressed both BMP and TGFβ signaling, and resulted in increased phospho-
p38 levels in frontofacial tissues. The sympathetic ganglia were also hypoplastic, 
and they produced significantly less tyrosine hydroxylase, which resulted in the 
mid-gestational lethality. Overexpression of Smad7 in later stage sympathetic 
ganglia after they have undergone differentiation, however, did not result in 
embryonic lethality and diminished tyrosine hydroxylase, demonstrating that 
TGFβ superfamily signaling in the sympathetic ganglia is critical for their 
differentiation but dispensable for their survival and homeostasis.  
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Materials & Methods 
Genotyping by PCR: 
Forward primer was designed within the myc tag sequence as followed: 5’-
ATCCACGCTGTTTTGACCTC-3’; reverse primer was designed locating 
downstream of Smad7 start codon ATG, as followed: 5’-
GAGCGCAGATCGTTTGGT-3’. This primer pair is used for genotyping tetOn-
Smad7 transgenic mice by PCR using mouse genomic DNA from tail with 
previously established protocols [76]. 
 
Mice maintenance: 
Rosa26R (R26r) Cre-reporter mice were purchased from the Jackson Labs (for 
detailed PCR-genotyping, see http://www.jax.org); the animals were maintained 
on a light-dark cycle with light from 06:00 to 18:00 hours. Embryonic age was 
determined by the vaginal plug, the noon of the day plug observed defined as 
E0.5. All mice were maintained on mixed genetic backgrounds. All studies were 
carried out at the Animal Care Facility of the Indiana University in accordance 
with national and institutional guidelines. 
 
X-Gal Staining: 
Whole embryos were stained for β-galactosidase activity based on established 
protocols. Briefly, embryos were fixed for 1 to 2 hours at room temperature in 4% 
paraformaldehyde. Fixed embryos were washed in PBS twice then incubated in 
β-galactosidase buffer (0.058 M Na2HPO4, 0.042 M NaH2PO4, 0.001 M MgCl2, 
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0.01% NP40) overnight. Next day, buffer was removed and substrate (0.1% X-
gal, 0.005 M K3Fe4(CN)6, 0.005 M K4Fe3(CN)6, 0.001 M EGTA) added to cover 
the embryos. The embryos were wrapped in aluminum foil and left in the dark at 
37ºC overnight. They are rinsed twice in PBS and post-fixed in 4% 
paraformaldehyde. The embryos were dehydrated through alcohol and 
embedded in paraffin. Sections were cut at 10 µm thickness and counterstained 
with Eosin. 
 
Apoptosis assay: 
Apoptotic cells were detected in paraffin-embedded tissue sections using TdT-
FragELTM DNA Fragmentation Detection Kit (Calbiochem). Assays were 
performed on 10 um paraffin sections. The total cells and positively stained cells 
were counted manually in defined areas of tissues under 40X magnification. 
Statistical analysis of cell counts in serial sections and comparison of trigenic 
specimens to controls was performed using one-tailed t-test. 
 
Western blot analyses: 
Tissues from embryos were homogenized in lysing buffer (0.02M Tris, 0.01M 
EDTA, 0.1M NaCl, 1% SDS) and analyzed using western blotting. Proteins were 
blotted onto PVDF membrane; Myc (Santa Cruz Biotech, A-14), Smad1 (Santa 
Cruz Biotech, sc-81378), phospho-Smad1/5/8 (cell signaling, 9511), Smad2/3 
(Santa Cruz Biotech, sc-8332), phospho-Smad2 (cell signaling, 3101), phospho-
p38 (cell signaling, 9211), p38 (cell signaling, 9212), phospho-Akt (cell signaling, 
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9271), Akt (cell signaling, 9272), tyrosine hydroxylase (Millipore, ab152), tubulin 
(Sigma, T-5168) antibodies were used.  
 
Immunohistochemistry Analysis:  
Immunohistochemistry was carried out using ABC kit (Vectorstain) with DAB and 
hydrogen peroxide as chromogens as previously described [78]. The dilution of 
primary antibody was 1:5000 for α-smooth muscle actin (αSMA; Sigma), 1:750 
for phospho-Smad1/5/8 (cell signaling, 9511), 1:1500 for phospho-Smad2 (cell 
signaling, 3101), 1:5000 for neuron specific beta III tubulin (NSβT; Abcam, 
ab18207), 1:10000 for tyrosine hydroxylase (Millipore, ab152). 
 
Implantation of isoproterenol osmotic minipump:  
Pregnant females (at various stages of gestation) were anesthetized in a 
chamber with isoflurane (2%)-oxygen (98%) mixture. Once anesthesia was 
achieved, the incision site was shaved with a 40-tooth blade, and loose hair 
blown off with compressed air or removed with tape, and cleaned twice with 
warm Betadine.  A sterile osmotic minipump (Alzet Osmotic Pump model #2001 
3cm x 0.7cm, flow rate of 1µl/hr) filled with 0.014g/ml isoproterenol (dissolved in 
saline) was then implanted through a small longitudinal incision (1/2") between 
the scapulae.   The mini osmotic pumps deliver drug subcutaneously from the 
pump; no catheters are involved. The wound was sutured closed and the mice 
housed 1 per cage to prevent fighting and wound reopening. The procedure, 
from anesthesia to final closure, takes about 5 minutes. Mice are kept in surgery 
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room until recovered (typically only 15-30 minutes), and then transferred to main 
mouse room prior to harvesting 1 week later. Animals were checked for redness, 
swelling and/or infection two days following implantation, and animals with signs 
of infection would be euthanized.  Only one surgical procedure was performed 
per animal and the pregnant dams harvested at E14 and E18 stages of 
gestation, and the resultant embryos/fetuses hearts analyzed.  
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Results 
Generation of Peri-Cre/R26rtTA-EGFP/tetO-Smad7 trigenic mice and 
examination of the kinetics of Smad7 induction in vivo 
In order to study the role of TGFβ family signaling in post-migratory NCC after 
they have reached their target tissues and organs, we used Peri-Cre transgenic 
mice, which has been shown to only mark a subpopulation of NCC undergoing 
differentiation ([122] and Conway lab unpublished data), to drive myc-Smad7 
expression. To visualize Cre activity in Peri-Cre marked post-migratory NCC, 
Peri-Cre mice were crossed to a Cre recombination reporter line, R26r [85]. 
Because the recombination mediated by Cre recombinase at R26R locus is 
irreversible, embryos carrying Peri-Cre; R26r express lacZ in all cells that 
express active Cre recombinase and their daughter cells. Peri-Cre; R26r E11.5 
embryos were whole mount stained with lacZ substrate for analysis. Whole 
mount staining showed robust lacZ expression in the frontonasal prominence, 
especially in the upper (maxillary) and lower jaw (mandible) (Fig. 14A, B), and in 
the peripheral nervous system, including the dorsal root ganglia (Fig. 14C). 
Sections through the cardiac OFT region showed robust lacZ expression in the 
endocardial cushions in the oft (Fig. 14D). LacZ also stained the dorsal root 
ganglia (drg) and sympathetic ganglia (sg) adjacent to the aorta (Fig. 14E, F), the 
derivatives from NCC.  
 
We crossed three individual transgenic mice, Peri-Cre (Conway lab), R26rtTA-EGFP 
(Jax lab) and tetO-Smad7 mice [42] to generate Peri-Cre/R26rtTA-EGFP/tetO-
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Smad7 trigenic mice (Fig. 15A). Male trigenic offspring were then crossed to 
homozygous female R26rtTA-EGFP mice and the resultant embryos were used for 
further investigation. As we reported in our Wnt1-Cre/R26rtTA-EGFP/tetO-Smad7 
trigenic study [42], the location and cell types that mycSmad7 will be induced is 
determined by Peri-Cre lineages; and the time of mycSmad7 induction is 
determined by when we apply doxycycline to the trigenic system. For simplicity, 
the embryos containing all three transgenes are referred to as trigenic embryos, 
and all other littermates are referred to as control embryos. As expected, when 
pregnant females were fed with normal chow, normal litter sizes (n=8 
embryos/litter from 4 litters) and trigenic offspring were recovered at expected 
Mendelian ratios when harvested at E13.5 (25.8%). Additionally, western 
analysis detected no myc-Smad7 protein expression in normal fed trigenic 
embryos (Fig. 15B). Without doxycycline feeding, these embryos develop 
normally, and they reach adulthood and can breed. 
 
When the food for pregnant females was switched from regular chow to 
doxycycline-containing food at E9.5 (prior to first appearance of Peri-Cre, 
unpublished data), the induction of myc-Smad7 protein was first detected after 5 
hours and myc-Smad7 induction reached its maximum level after 24 hours in 
trigenic embryos, and myc-Smad7 protein induction was observed only in trigenic 
embryos (Fig. 15B). This rapid induction is consistent with other studies that have 
shown rtTA-driven transgene expression is detectable 6 hours after onset of 
doxycycline treatment [83, 123].    
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Combined, these data demonstrate that transgenic myc-Smad7 expression is 
tightly controlled in Peri-Cre/R26rtTA-EGFP/tetO-Smad7 trigenic system, and that 
myc-Smad7 expression is induced rapidly in trigenic embryos by application of 
doxycycline to the system. 
 
Overexpression of Smad7 in the post-migratory neural crest cells impaired 
normal facial and pharyngeal arch development, and resulted in mid-
gestational lethality 
After confirm the inducibility of Smad7 in the Peri-Cre/R26rtTA-EGFP/tetO-Smad7 
trigenic system, we used this system to examine the roles of regulated TGFβ 
superfamily signaling in post-migratory neural crest cell development. 
Specifically, we bred Peri-Cre/TetO-Smad7/ROSA26RrtTA-EGFP male trigenic mice 
with female homozygous ROSA26RrtTA-EGFP mice to generate trigenic and control 
embryos. Peri-Cre activity can be detected as early as E9.5, so we switched the 
pregnant mice from the regular food to doxycycline containing food at E9.5; then 
we harvested embryos after 6, 24, 48, 60 hours (corresponding to E9.5, E10.5, 
E11.5 and E12.5, respectively). At E9.5 (5 hours), the trigenic embryos (Fig. 16B, 
n=4) displayed no morphological differences to the controls (Fig. 16A).  At E10.5 
(24 hours), trigenic embryos showed hypoplastic 1st and 2nd pharyngeal arches 
(arrows in Fig. 16D, n=11) and smaller upper jaws (arrows in Fig. 16F, n=20), 
and a ventral view of those embryos demonstrated smaller maxillary component 
of first pharyngeal arch and un-fused mandibular component of the first 
pharyngeal arch (arrow in Fig. 16H) compared to littermate control embryos (Fig. 
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16G). At E11.5, the trigenic embryos had severe blood pooling throughout the 
body, and were missing face and jaw structures (arrow in Fig. 16J, n=22). At 
E12.5, in addition to missing face and jaw and blood pooling, there was lack of 
blood in the yolk sac blood vessels in trigenic embryos (arrow in Fig. 16N, n=13), 
suggesting a dysfunctional circulation system in the trigenic embryos. No trigenic 
embryos could survive beyond E12.5. Thus, overexpression of Smad7 in the 
post-migratory neural crest cells results in abnormal facial and pharyngeal arch 
development, and mid-gestational lethality.  
 
Overexpression of Smad7 in post-migratory neural crest cells affected 
sympathetic ganglia but not dorsal root ganglia and cardiac development  
After migrating out of the neural tube, NCC reach the dorsal aorta by E9.5, and 
those cells begin to aggregate in the adjacent area around the dorsal aorta and 
differentiate and form compact sympathetic ganglia (sg) by E10.5 (Fig. 17A, C). 
In trigenic embryos, the sympathetic ganglia were still formed but in diminished 
size (Fig. 17B, D), indicating overexpression of Smad7 in post-migratory NCC 
affected the normal development of these sympathetic ganglia. Located next to 
the neural tube, dorsal root ganglia (drg) are also differentiated from post-
migratory NCC. Consistent with previous reports [21, 39, 42], the size and shape 
of DRG in trigenic embryos (Fig. 5B) were comparable to those in the control 
embryos (Fig. 17A). The sympathetic ganglia adjacent to the dorsal aorta are 
responsible for the production of epinephrine and norepinephrine at this 
embryonic stage, while dorsal root ganglia are the sensory division of the 
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peripheral nervous system, the above data suggest that overexpression of 
Smad7 in post-migratory NCC affects the noradrenergic sympathetic ganglia, not 
sensory ganglia at this stage.  
 
NCC migrate to the cardiac OFT region and differentiate into specific cell types to 
separate the single OFT into ascending aorta and pulmonary artery.  To further 
examine the effects of overexpression of Smad7 in those post-migratory NCC in 
the OFT, control and trigenic embryos (Fig. 17E, F) were transversely sectioned 
and H&E stained. At E10.5, the endocardial cushions were formed normally in 
the trigenic embryos (Fig. 17F) when compared to control littermates (Fig. 17E), 
indicating that OFT endocardial cushions are not affected by overexpression of 
Smad7 in post-migratory NCC at this stage.  
 
Increased cell death caused hypoplastic pharyngeal arches and 
frontofacial tissue phenotypes 
Given the observed facial and pharyngeal arch hypoplasia, TUNEL assays were 
used to examine apoptosis within control (Fig. 18A, C) and trigenic (Fig. 18B, D) 
embryos. Significantly elevated levels of apoptotic positive cells (brown) were 
present within the first and second pharyngeal arches in the trigenic embryo (Fig. 
18B, D). When TUNEL positive cells were tallied as a percentage of total cells to 
calculate a cell death index, there was a significant increase in cell death in 
trigenic embryos (4.1% in controls versus 31.6% in trigenics, P<0.001, Fig. 18E). 
Since the upper and lower jaws are derived from first pharyngeal arches, the 
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TUNEL data demonstrated that the observed hypoplastic facial and pharyngeal 
arches in trigenic embryos resulted from elevated apoptosis. However, there was 
only a few apoptotic cells presence in the OFT cushions in both control (Fig. 18F, 
H) and trigenic embryos (Fig. 18G, I) and there was no statistical difference in 
terms of TUNEL staining between control and trigenic embryos (Fig. 18J). This 
data explained why we did not see abnormal OFT cushions in the trigenic 
embryos.  
 
Increased phospho-p38 in pharyngeal arches and frontofacial tissues 
Given the observed difference in apoptosis between pharyngeal arches and 
frontofacial tissues and hearts, E10.5 hearts and frontofacial tissues (including 
upper and lower jaws, 1st and 2nd pharyngeal arches) were microdissected. 
Tissues from 3 embryos were pooled to gain enough protein for western blotting 
analysis. Note that myc-Smad7 is only expressed within pooled (n=3) trigenic 
E10.5 hearts and frontofacial tissues, not in pooled control (n=3) samples (Fig. 
19A). In the heart samples, myc-Smad7 suppressed pSmad1/5/8 by ~70%, 
pSmad2 by ~60% (Fig. 19A, B) when normalized to their respective total proteins 
compared to their controls. In the frontofacial sample, myc-Smad7 suppressed 
pSmad1/5/8 by ~90%, pSmad2 by ~87% (Fig. 19A, B). These data showed that 
overexpression of mycSmad7 suppressed both BMP and TGFβ signaling in both 
heart and frontofacial tissues.  
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Although Smad7 was originally identified as an inhibitory Smad of TGFβ, there 
are several reports suggesting that inhibitory Smads may have other cellular 
functions. In one report, overexpression of Smad7 by adenoviral infection 
induced DNA fragmentation and significant increases in cell death in rat 
mesangial cells [124]. In another report, Smad7 has been shown to be involved 
in TGFβ-induced apoptosis of prostate cancer cells by activating p38 [125]. To 
address these reports and further probe the mechanism underlying our observed 
defects, we measured p38 levels in samples from both heart and frontofacial 
regions. Indeed, the phospho-p38 levels were increased ~ 5.6 fold in frontofacial 
tissues, while its levels were unchanged in the heart (Fig. 19A, B). It has also 
been shown that Smad7 overexpression might antagonize pro-survival signals, 
such as Akt. However, our western blotting data revealed phospho-Akt levels 
were down in both the heart (11%) and frontofacial tissues (10%). Taken 
together, these data demonstrate that increased phospho-p38 may be primarily 
responsible for the increased apoptosis observed in Smad7 overexpressing post-
migratory neural crest observed in frontofacial regions of trigenic embryos. 
 
Trigenic heart and blood vessels were unaffected 
Since we observed blood pooling in E11.5 trigenic embryos, which could indicate 
a malfunctional circulatory system, we hypothesized that the heart might be 
primarily affected.  We examined myocardial development in both control and 
trigenic embryos using α-smooth muscle actin (αSMA) immunohistochemistry 
assay since αSMA stains both smooth muscle cells and the cardiomyocytes in 
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embryonic stages. The αSMA staining revealed that the myocardium of the 
trigenic embryos was unaffected (Fig. 20B) when compared to control littermates 
(Fig. 20A).  The other major component of circulation system is the blood 
vessels. NCC contribute to the supportive smooth muscle layer surrounding 
peripheral vasculature of the great vessels that exit the heart [126-128]. 
However, αSMA immunohistochemistry on cross section of E11.5 blood pooling 
trigenic embryos displayed no evidence of leaky hemorrhagic blood vessels in 
either pharyngeal arch arteries (not shown) or dorsal aorta (Fig. 20D, F). The 
αSMA immunohistochemistry staining detected no differences between control 
(Fig. 20C, E) and trigenic embryos (Fig. 20D, F) before the onset of lethality and 
embryonic necrosis. Therefore, our data demonstrated that the circulation 
problem in trigenic embryos was not caused by either abnormal formation of 
myocardium or blood vessels. 
 
Dramatically decreased Tyrosine Hydroxylase (TH) was the underlying 
cause of trigenic mid-gestational lethality  
Although the observed blood pooling could indicate a potential circulation 
problem in the trigenic embryos, our analysis demonstrated that the OFT 
cushions, myocardium and blood vessels were normal in trigenic embryos (Fig. 
17F, Fig. 20B, and Fig. 20D, F). This discrepancy prompted us to examine other 
aspects of the circulation system and cardiac function. Since neural crest cells 
initiate adrenergic differentiation in the vicinity of dorsal aorta to form the primary 
sympathetic strands and Peri-Cre is known to drive gene expression in the 
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peripheral nervous system [122], we performed Neuron Specific β III Tubulin 
(NSβT) immunohistochemistry, which labels all neurons in central nervous 
system and peripheral nervous system, on cross sectioned control and trigenic 
embryos at E10.5. NSβT staining revealed that the sympathetic ganglia were 
much smaller in trigenics (Fig. 21B, D) than in the controls (Fig. 21A, C) but were 
present. Sympathetic ganglia in embryos are responsible for synthesis and 
transport of neurotransmitters, such as epinephrine and norepinephrine. Tyrosine 
hydroxylase, the rate-limiting enzyme in catecholamine synthesis, is a marker 
when NCC take the catecholaminergic phenotype [28], so we examined its 
expression. TH immunostaining showed significantly reduced TH expression 
within the trigenic sympathetic ganglia (Fig. 21F, H). This data suggested that 
there might be less epinephrine and norepinephrine in the circulating blood in 
trigenic embryos, which in turn decreased the heart beat and eventually results in 
in utero cardic failure and hemodynamic overload. This would then result in the 
observed blood pooling in blood vessels (Fig. 16J). To test this hypothesis, we 
used isoproterenol, an epinephrine homolog, to artificially increase the 
catecholamine levels in trigenic embryos. An isoproterenol mini-osmotic pump 
was implanted into the pregnant females at E8.5 when they were on regular 
chow. The pregnant females were then switched to doxycycline food at E9.5, and 
the embryos were then harvested at E14.5. The embryos still demonstrated 
hypoplastic facial and other abnormalities (Fig. 22B), but significantly, they were 
still alive. Thus, these data was consistent with our hypothesis that dramatically 
decreased TH expression and reduced circulatory norepinephrine levels in 
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trigenics was the underlying cause of the observed mid-gestational lethality, as 
isoproterenol could fully rescue the non-viable embryos until birth (Fig. 22B, n=2).  
 
Overexpression of Smad7 in post-differentiated sympathetic ganglia did 
not result in mid-gestational lethality  
NCC reach the dorsal aorta by E9.5, and differentiate and form compact 
sympathetic ganglia (sg) by E10.5 (Fig. 17A, C). To bypass the early lethality 
observed in trigenic embryos and take advantage of our inducible system, we 
induced mycSmad7 expression starting from E12.5.  We crossed Peri-Cre/TetO-
Smad7/ROSA26RrtTA-EGFP male trigenic mice with female homozygous 
ROSA26RrtTA-EGFP mice and fed the pregnant females doxycycline containing 
food at E12.5, and then harvested embryos at E14.5. Significantly, all trigenic 
embryos (Fig. 23B, n=8) harvested were alive and grossly normal when 
compared to littermate controls (Fig. 23A). TH immunohistochemistry assays on 
crossed sectioned embryos revealed normal and abundant TH staining within 
sympathetic ganglia adjacent to the dorsal aorta in both control (Fig. 23C, E) and 
trigenic embryos (Fig. 23D, F). The size and shape of the sympathetic ganglia 
also appeared normal in trigenic embryos (Fig. 23D, F). Western blotting showed 
that overexpression of mycSmad7 still suppressed both BMP and TGFβ 
signaling, demonstrated by decreased pSmad1/5/8 and pSmad2 levels, 
respectively (Fig. 23G), but the TH expression levels in trigenic embryos are 
comparable to those in control embryos (Fig. 23G).  These data demonstrated 
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that TGFβ superfamily signaling in the sympathetic ganglia is critical for their 
normal differentiation but dispensable for their survival.   
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Discussion 
This project used the Peri-Cre line in our trigenic system to drive Smad7 
overexpression. It was a similar yet different system from our previous Wnt1-
Cre/R26rtTA-EGFP/tetO-Smad7 analysis [42]. Principally, as Wnt1-Cre is known to 
be expressed prior to NCC emigration out of neural tube, it not only marks 
significantly more NCC subpopulations, it is also expressed in undifferentiated 
NCC lineages [14, 20]. However, Peri-Cre marks specifically the peripheral 
nervous system and the endocardial cushions within the OFT, only a 
subpopulation of post-migratory NCC when they are undergoing the critical steps 
of differentiation and cell fate specialization (Conway lab). Thus, via use of 
overexpression of Smad7 in Wnt1-Cre trigenic system, we were able to 
investigate the role and effects upon TGFβ superfamily signaling role in pre-
migratory NCC. Overexpression of Smad7 in Peri-Cre trigenic system, we were 
able to investigate the effects of TGFβ superfamily signaling suppression in only 
a subpopulation of post-migratory NCC.  
 
Similar to the Wnt1-Cre trigenic system, the data from Peri-Cre trigenic system 
demonstrated that forced expression of Smad7 within a subpopulation of post-
migratory NCC was detrimental to development of NCC and their derivatives, 
resulted in hypoplastic frontofacial tissues, and reduced 1st and 2nd pharyngeal 
arches. Moreover, we showed that levels of both TGFβ and BMP phosphorylated 
R-Smads were reduced in the NCC lineages expressing myc-Smad7, providing 
additional confirmatory evidence that TGFβ superfamily signaling is impaired in 
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vivo by myc-Smad7 induction in NCC. In addition, we demonstrated that the 
hypoplastic or missing tissues observed in Peri-Cre trigenic mouse model were 
caused by elevated apoptosis in Smad7 overexpressing cells and their 
neighboring cells, indicating Smad7 mediated TGFβ superfamily signaling or 
Smad7 itself or both were probably important for NCC differentiation,  specialized  
cell maintenance and survival.  
 
Since Wnt1-Cre is thought to label all NCC lineages but Peri-Cre only marks a 
subpopulation of post-migratory NCC, we expected overexpression of Smad7 in 
Wnt1-Cre lineages would have resulted in more severe phenotypes than that in 
Peri-Cre lineages. However, we observed the opposite: there was embryonic 
lethality at E12.5 in Peri-Cre/R26rtTA-EGFP/tetO-Smad7 trigenic mouse model, 
much earlier than the observed lethality at birth in our Wnt1-Cre/R26rtTA-
EGFP/tetO-Smad7 trigenic mouse [42]. One probable explanation is the difference 
between Wnt1-Cre and Peri-Cre expression patterns. Peri-Cre is robustly 
expressed in all sympathetic ganglia along all axial levels (unpublished data, 
Conway lab), so that Smad7 overexpression in Peri-Cre lineages likely affects all 
sympathetic ganglia differentiation, thus resulting in less epinephrine and 
norepinephrine in the circulating blood in trigenic embryos, which in turn 
decreased the heart beat and eventually results in in utero cardiac failure and 
mid-gestational lethality. However, Wnt1-Cre seems to not mark all the 
sympathetic ganglia along all axial levels. Wnt1-Cre lineage tracing experiments 
by crossing with Rosa26 reporter [85] mice show Wnt-Cre mediated lacZ gene 
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expression starts in the rostral hindbrain around the four somite (E8.0) stage and 
extends anterior to the midbrain, forebrain, and posterior to the caudal hindbrain, 
cardiac and trunk levels by eight somite (E8.5) stage [39]. However, once NCC 
have formed, they migrate out of the neural tube at all axis levels simultaneously. 
So it could be that some more posterior NCC could have already migrated out of 
the neural tube prior to Wnt1-Cre expression at those axial levels. Those 
posterior migrated NCC may be differentiated normally into sympathetic ganglia, 
which then produce enough epinephrine and norepinephrine for the trigenic 
survival. Indeed, in support of this hypothesis, when diphtheria toxin A fragment 
(DTA), a fatal toxin that kills cells autonomously, was expressed in Wnt1-Cre 
lineages, Wnt1-Cre;DTA embryos survive to birth and developed normal adrenal 
glands even though the medullar portion of the adrenal gland is derived from 
NCC (unpublished data, Conway lab). Another possible explanation could be 
from the different developmental stages that the Cre mouse lines express. Wnt1-
Cre expresses before NCC migrate out the neural tube, and Peri-Cre expresses 
in post-migratory NCC when they are undergoing differentiation. So it could be 
that TGFβ superfamily signaling or Smad7 itself or both play a more important 
role in NCC differentiation stage than they do in the stages before NCC 
migration. The third explanation could be as simple as these two Cre mouse lines 
drive gene expression in some common but not completely overlapping cell 
populations, thus we observed different results in those two trigenic Smad7 
overexpression mouse models.   
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Figure 14. Peri-Cre early lineage mapping. To lineage map Peri-Cre 
populations, Peri-Cre transgenic mice were crossed with R26r lacZ reporter 
mice, Peri-Cre; R26r/+ E11.5 embryos were then whole mount stained with lacZ 
substrate. (A-C) Whole mount lacZ staining showed robust lacZ expression in 
frontonasal prominence, especially in the upper (maxillary) and lower jaw 
(mandible) (A, B), and peripheral nervous system (C).   (D) Sections through the 
cardiac (oft) region showed robust lacZ expression in the endocardial cushions in 
the oft. (E) LacZ stained the dorsal root ganglia (drg) and sympathetic ganglia 
(sg) adjacent to the aorta. (F) Higher magnification showing lacZ positive cells in 
the sympathetic ganglia (sg) adjacent to the aorta. Abbreviations: dAo, dorsal 
aorta; drg, dorsal root ganglia; h, heart; mand, mandible; max, maxillary; nt, 
neural tube; oft, outflow tract; sg, sympathetical ganglia.  
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Figure 15. Smad7 induction kinetics in doxycycline inducible Peri-
Cre/R26rtTA-EGFP/tetO-Smad7 trigenic mouse system. (A) Schematic illustrating 
operation of the trigenic system. The R26rtTA-EGFP knockin mice will only express 
the rtTA from the Rosa26 locus upon Cre-mediated recombination [74]. Peri-Cre 
transgenic mice have been shown to label peripheral nervous system [122]. In 
the tetO-Smad7 transgenic mice, myc-Smad7 full length cDNA is under the 
control of heptamerized tetOn promoter, but Smad7 is not expressed until both 
the transactivator (rtTA) and inducer (doxycycline) are present within the same 
cell. Although all three transgenes are individually silent within the compound 
trigenic mice, myc-tagged Smad7 can be specifically induced within Cre-positive 
lineages upon doxycycline feeding. Thus, the spatiotemporal timing of myc-
tagged Smad7 expression is determined by the timing of doxycycline addition 
and positionally by the expression of Cre recombinase. (B) Western blotting 
showed no myc-Smad7 expression in E13.5 embryos fed with normal chow.  
However, when the pregnant mothers were fed doxycycline (Dox) containing 
food at E9.5 myc-Smad7 could be detected after 5 hours, indicating quick 
induction of this system. Myc-Smad induction reached maximum levels after 24 
hours as indicated by comparable myc-Smad7 levels in E10.5 and E11.5 
embryos.  
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Figure 16.  Overexpression of Smad7 in the post-migratory neural crest 
cells impaired normal facial and pharyngeal arch development, and 
resulted in mid-gestational lethality. All embryos were fed Dox food at E9.5 
(A, B) Trigenic embryos (B) were grossly normal compared to littermate control 
embryos (A) after being fed with Dox for 5 hours. (C-H) E10.5 control (C, E, G) 
and trigenic (D, F, H) whole embryos. Trigenic embryos were largely comparable 
to the control embryos at this stage except for hypoplastic 1st and 2nd pharyngeal 
arches (PA) (insert in D), and less outgrowth of the frontofacial process (arrows 
in F). Besides, the mandibular component of the 1st PA was starting to fuse in the 
control littermates (G), while that fusion did not occur in the trigenic embryos 
(arrow in H). (I-L) E11.5 control (I, K) and trigenic (J, L) whole embryos. Trigenic 
embryos showed blood pooling in the blood vessels (arrow in J) and the heart 
and missing frontofacial tissues (arrow in L). Ventral view showed missing 
maxillary and mandible in the trigenic embryos (L). (M-P) E11.5 control (M, O) 
and trigenic (N, P) whole embryos. There was lack of blood in the yolk sac blood 
vessels in the trigenic embryos (arrow in N); trigenic embryos die by E12.5 (P). 
Abbreviations: 1, first pharyngeal arch; 2, second pharyngeal arch; h, heart; 
mand, mandible; max, maxillary. 
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Figure 17. Overexpression of Smad7 in post-migratory neural crest cells 
affected sympathetic ganglia but not dorsal root ganglia and cardiac 
development. Littermate control and trigenic embryos were cross sectioned and 
stained with H&E. (A, B) The size and shape of dorsal root ganglia were 
comparable in both trigenic (B) and control (A) embryos. (C, D) However, the 
catecholaminergic sympathetic ganglia adjacent to the dorsal aorta were much 
smaller in the trigenic embryos. (E, F) The size of the endocardial cushions in the 
OFT were similar to that of the controls. Abbreviations: dAo, dorsal aorta; drg, 
dorsal root ganglia; e, esophagus; nt, neural tube; oft, outflow tract; rv, right 
ventricle; sg, sympathetical ganglia; t, trachea.  
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Figure 18. Elevated cell death in craniofacial regions of the Smad7 trigenic 
mutants. (A-E) TUNEL staining on cross sections through the pharyngeal arches 
of the control (A, C) and trigenic embryos (B, D) at E10.5 (n=4) demonstrated a 
notable increase in cell death in trigenic mutants (B, D) within the mandibular 
component of the 1st and 2nd pharyngeal arches (arrows in D) compared to 
controls (C). The apoptotic cell index was statistically significant higher in the 
trigenics (31.57%, E) than that of controls (4.12%, E).  (F-J) TUNEL staining on 
cross sections through the outflow tract of the control (A, C) and trigenic embryos 
(B, D) at E10.5 (n=4). Note that positive TUNEL signals were evident in both 
control (arrow, F) and trigenic (arrow, G) foregut regions, which have been 
known to have high endogenous apoptosis activity. However, there were only 
few sporadic distributed apoptotic cells in both control (arrows in H) and trigenic 
(arrows in I) embryo OFT regions. There was no notable difference in terms of 
apoptotic cell rate in the OFT cushions between the control (1.87%) and trigenic 
(1.82%) embryos (J). Abbreviations: 1, first pharyngeal arch; 2, second 
pharyngeal arch; ec, endocardial cushions; lv, left ventricle; oft, outflow tract; rv, 
right ventricle.  
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Figure 19. Increased pp38 in pharyngeal arches and frontofacial tissues. 
(A) E10.5 hearts and frontofacial tissues (including upper and lower jaws, 1st and 
2nd pharyngeal arches) were microdissected and examined by western analysis. 
Note that myc-Smad7 is only expressed within pooled (n=3) trigenic E10.5 hearts 
and frontofacial tissues, not in pooled control (n=3) samples. In the heart sample, 
myc-Smad7 suppressed pSmad1/5/8 by ~70%, pSmad2 ~60%, pp38 
unchanged, and pAkt ~11% (A, B) when normalized to their respective total 
proteins compared to littermate controls. In frontofacial sample, where the tissues 
are known to be mostly populated by Peri-Cre lineages, presence of myc-Smad7 
suppressed pSmad1/5/8 by ~90%, pSmad2 ~87%, pAkt ~10%, but pp38 levels 
were increased by 5.6 fold (A, B). Abbreviations: con, control embryos; tri, 
trigenic Wnt1-Cre/RosartTA-EGFP/tetO-Smad7 embryos; heart, pooled heart 
tissues; PA, pooled frontofacial tissues (including upper and lower jaws, 1st and 
2nd pharyngeal arches); pp38, phospho-p38; pAkt, phospho-Akt; pSmad1/5/8, 
phospho-Smad1/5/8; pSmad2, phospho-Smad2. 
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Figure 20. Unaffected cardiac structure and intact blood vessels in trigenic 
embryos.  (A, B) αSM-actin staining showed normal developed myocardium in 
trigenic embryos (B) compared to the controls (A). (C-F) αSM-actin staining 
showed normal smooth muscle layers surrounding the dorsal aorta in the trigenic 
embryos (D, F) compared to controls (C, E). Abbreviations: dAo, dorsal aorta; lv, 
left ventricle; rv, right ventricle. 
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Figure 21. Hypoplastic sympathetic ganglia and decreased TH synthesis in 
trigenics. (A-D) NSβT staining showed that the trigenic (B, D) para-aorta 
sympathetic ganglia were smaller than that of controls (A, C). (E-H) TH staining 
demonstrated that there was much lower TH expression in the trigenic 
sympathetic ganglia (F, H) compared to controls (E, G). Abbreviations: dAo, 
dorsal aorta; sg, sympathetical ganglia.  
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Figure 22. Isoproterenol rescued trigenic embryos. Isoproterenol pump was 
inserted under the skin of pregnant females at E8.5, females were then switched 
to doxycycline containing food at E9.5, and embryos were harvested at E14.5. 
(A) Control embryos. (B) Trigenic embryos. Trigenic embryos were alive when 
harvested at E14.5, even though they still had hypoplastic jaws and abnormal 
developed limbs.  
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Figure 23. Overexpression of Smad7 in post-differentiated sympathetic 
ganglia did not result in mid-gestational lethality. Embryos were fed 
doxycycline food from E12.5 and harvested at E14.5. (A, B) Trigenic embryos (B, 
n=8) were alive and grossly normal compared to controls (A). (C-F) TH 
immunohistochemistry assay on crossed sectioned embryos showed normal and 
abundant staining on sympathetic ganglia adjacent to the dorsal aorta in both 
control (C, E) and trigenic embryos (D, F). The size and shape of the sympathetic 
ganglia also appeared normal in trigenic embryos (D, F). (G) Western blotting 
showed that overexpression of mycSmad7 still suppressed both BMP and TGFβ 
signaling, demonstrated by decreased pSmad1/5/8 and pSmad2 levels, 
respectively, but the TH expression levels in trigenic embryos were comparable 
to those in control embryos. Abbreviations: dAo, dorsal aorta; drg, dorsal root 
ganglia; e, esophagus; nt, neural tube; sg, sympathetical ganglia; t, trachea. 
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Chapter VI:  Discussion 
 
A. The purpose of creating the inducible trigenic mouse system 
Neural crest cells (NCC) are a transient population of cells formed during early 
vertebrate embryonic development. NCC are multipotent cells. After neurulation, 
they delaminate and migrate along defined pathways to contribute to the 
formation of a wide variety target tissues, including neurons and glia of the 
peripheral nervous system, melanocytes, smooth muscle cells and most 
craniofacial cartilages and bones [12, 14, 63]. NCC also contribute crucial cell 
populations to several thoracic tissues, including the developing aortic arch 
arteries (AAA) and OFT of the heart [13, 20, 64-65].  
 
TGFβ superfamily signaling has been shown playing critical roles in NCC 
development. Systemic or conditional knock out of the components of TGFβ 
superfamily signaling resulted in various NCC development defects [28-41]. 
However, normal NCC development is determined by expressing genes at both 
the right time and right place. Systemic knock out mouse models can not address 
where and when gene expression is important. Using mouse models based on 
Cre/loxp recombination can partially address this issue in that this method can 
target gene knock out or expression in certain confined cell types or tissues at a 
specific time point.  In my thesis project, I built a triple transgenic (trigenic) 
system to address the issue of expressing genes at both the right time and right 
place. This system uses not only Cre/loxp recombination but also doxycycline 
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induction elements. By using this system, where a gene is expressed is 
determined by the Cre mouse line used, and when that gene is expressed is 
controlled by when I apply the inducer, doxycycline, to the system. The inclusion 
of doxycycline induction elements adds a further temporal control for gene 
expression, allowing me to induce gene expression at different time points 
instead of only one time point that is determined by Cre expression in mouse 
model systems based on only Cre/loxp recombination. To study NCC 
development, I used Wnt1-Cre and Peri-Cre transgenic mice. Wnt1-Cre has 
been shown to express before NCC migrate out of neural tube and so it marks all 
NCC lineages [14, 20]. Peri-Cre marks the peripheral nervous system, and the 
endocardial cushions of the OFT, which are a subpopulation of post-migratory 
NCC when they are undergoing differentiation (Conway lab). 
 
B. The reasons of using Smad7 to study NCC development 
There were two major reasons why I chose to overexpress Smad7 in my trigenic 
system. First of all, Smad7 is negatively regulates TGFβ superfamily signaling in 
vitro [4-8]. Since TGFβ superfamily signaling is known to play important roles in 
NCC development, we are using Smad7 as a tool to negatively regulate TGFβ 
superfamily signaling. Second, we also want to know the possible roles of 
endogenous Smad7 in NCC development. Endogenous Smad7 mRNA is 
transiently activated pre-implantation, then is re-expressed widely post-
gastrulation [100]. In E10 and E12.5 embryos, Smad7 mRNA is widespread 
outside the developing central nervous system, including the NCC-derived 
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mandibular and medial nasal processes, developing pharyngeal arches, OFT 
cushions of the heart, adrenal primordium and trigeminal ganglion [55, 100]. 
Transgenic reporter and Cre/loxP lineage mapping using a partial Smad7 
promoter have also confirmed the robust expression of Smad7 mRNA within the 
craniofacial, pharyngeal arch and cardiovascular system [75, 101].  
 
C. The common results from Wnt1-Cre and Peri-Cre trigenic mouse models 
Our data provide compelling genetic evidence demonstrating that forced 
expression of Smad7 within NCC is detrimental to development of NCC and their 
derivatives. Moreover, we showed that levels of both TGFβ and BMP 
phosphorylated R-Smads were reduced in the NCC lineages expressing myc-
Smad7. Since TGFβ superfamily signaling is known to increase production of 
phosphorylated forms of R-Smad proteins, our data provide good evidence that 
TGFβ signaling in vivo is impaired by myc-Smad7 induction in NCC. In addition, 
we showed that the hypoplastic or missing tissues observed in both Wnt1-Cre 
and Peri-Cre trigenic mouse models were caused by elevated apoptosis in 
Smad7 overexpressing cells and their neighboring cells, indicating Smad7 
mediated TGFβ superfamily signaling or Smad7 itself or both were probably 
important for NCC differentiation,  differentiated cell maintenance and survival.  
 
D. The differences between Wnt1-Cre and Peri-Cre trigenic mouse models 
Since Wnt1-Cre marks all NCC lineages and Peri-Cre marks only a 
subpopulation of post-migratory NCC, we expected overexpression of Smad7 in 
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Wnt1-Cre lineages would have more severe phenotypes than that in Peri-Cre 
lineages. However, we observed embryonic lethality at E12.5 in Peri-Cre/R26rtTA-
EGFP/tetO-Smad7 trigenic mouse model, much earlier than that observed in Wnt1-
Cre/R26rtTA-EGFP/tetO-Smad7 trigenic mouse. One probable explanation is the 
Wnt1-Cre expression pattern. Wnt1-Cre lineage tracing by crossing with Rosa26 
reporter [85] mice show Wnt-Cre mediated lacZ gene expression starts in the 
rostral hindbrain around the four somite (E8.0) stage and extends anteriorly to 
the midbrain, forebrain, and posteriorly to the caudal hindbrain, cardiac and trunk 
levels by eight somite (E8.5) stage [39]. However, once NCC have formed, they 
migrate out of the neural tube at all axis levels simultaneously. So it could be that 
some NCC have already migrated out of the neural tube before Wnt1-Cre 
expresses at certain axis levels. Indeed, when diphtheria toxin A fragment (DTA), 
a fatal toxin that kills cells autonomously, was expressed in Wnt1-Cre lineages, 
Wnt1-Cre;DTA embryos survive to birth and developed normal adrenal glands 
(unpublished data, Conway lab), even though the medullar portion of the adrenal 
gland is derived from NCC. Another possible explanation could be from the 
difference those two Cre mouse lines express at developmental stages. Wnt1-
Cre expresses before NCC migrate out the neural tube, and Peri-Cre expresses 
in post-migratory NCC when they are undergoing differentiation. So it could be 
that TGFβ superfamily signaling or Smad7 itself or both play a more important 
role in the NCC differentiation stage than they do in the stages before NCC 
migration. The third explanation could be as simple as these two Cre mouse lines 
drive gene expression in some common but not completely overlapping cell 
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populations, thus we observed different results in the two trigenic Smad7 
overexpression mouse models.   
 
E. Smad7 and its role in apoptosis 
Like other Smads, Smad7 shuttles between the nucleus and the cytoplasm [129-
131]. In resting cells, Smad7 is localized in the nucleus. In response to TGFβ 
stimulation Smad7 is exported to the cytoplasm [129] to negatively regulate 
TGFβ superfamily signaling.   
 
Although Smad7 was originally identified as an inhibitory Smad for TGFβ 
superfamily signaling, there are several reports suggesting that Smad7 may have 
other cellular functions and can cooperate with TGFβ to show some other 
activities. It has been shown to interact with histone deacetylase 1 [132] to 
modulate gene expression. Smad7 can also regulate gene transcription by 
modulating its phosphorylation status [133]. Over-expression of Smad7 has 
recently been demonstrated to cause activation of the JNK pathway and 
apoptosis in MvLu1 (epithelial cells), MDCK (epithelial cells) and COS7 cells 
(African Green Monkey SV40-transferred kidney fibroblast cell line), suggesting 
roles of the Smad7 in regulation of the MAP kinase pathways [134]. 
 
My thesis project supports the idea that Smad7 plays other roles other than just 
suppresses TGFβ superfamily signaling via Smad. In both mouse models, we 
observed elevated apoptosis in Smad7 overexpressing tissues. Since 
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pSmad1/5/8 and pSmad2 levels were both downregulated in these two mouse 
models, we speculated that increased apoptosis in various tissues was caused 
by suppression of TGFβ superfamily signaling. In the Peri trigenic model, we also 
showed that phospho-p38 levels were upregulated in tissues with elevated 
apoptosis. TGFβ superfamily signaling can mediate cell undergo apoptosis via 
p38 pathway. What makes this observation interesting is that Smad7 may play a 
role as a mediator in this process. Indeed, Smad7 was reported to be involved in 
TGFβ-induced apoptosis of prostate cancer cells by activating p38 via TGFβ-
activated kinase 1 (TAK1) and MAPK kinase (MKK3) [125]. Besides, Smad7 is 
reported to promote apoptosis in keratinocyte cell lines [135]. In yet another 
report, over-expression of Smad7 by adenoviral infection induced DNA 
fragmentation and significant increases in cell death in rat mesangial cells [124]. 
However, in other reports, Smad7 has been showed to inhibit apoptosis induced 
by TGFβ in B cells [136] and Hep3B cells [137]. So it seems that Smad7’s ability 
to pro- or anti-apoptosis is dependent on different cell types, and it might function 
as a TGFβ superfamily signaling mediator or by other mechanisms. Therefore, 
the role Smad7 plays in cells or tissues largely depend on the balance between 
different signals the cells or tissues get, which is important for determining cell 
fate, survival or death. 
 
In my thesis, I was able to use the doxycycline inducible trigenic mouse model to 
study TGFβ superfamily roles in a really defined time window, so that I was able 
to observe different yet interesting phenotypes that people who are using 
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systemic or conditional knock out methods are unable to see. I think that my 
method for conditional myc-Smad7 expression are useful for elucidating further 
TGFβ superfamily roles in other organs and tissues and addressing the biological 
significance of the concerted action between growth and transcription factors in 
regulating normal development and disease. 
 
F. Future studies 
Despite being the foremost congenital heart defect (CHD) found in patients, 
isolated VSD in mice mutants are usually found in association with altered 
myocardial growth, OFT/AAA abnormalities and/or valvular defects [138]. VSD 
pathogenesis is complex and multifactorial: it may result from defects in the NCC, 
cardiomyocyte, endothelial, endocardial cushion, epicardial and/or cardiac 
fibroblast lineages because each of the above defects can alter left-right 
ventricular morphogenesis, chamber formation and septal positioning. In chapter 
II, we were able to obtain isolated VSD mouse model by feeding trigenic embryos 
after the cardiac NCC have colonized the OFT even though we do not know what 
are the mechanism underlying this defect. Future studies focusing on dissecting 
the molecular mechanism of this mouse model will prove useful to address the 
role of the NCC lineage in these CHDs.  
 
Another interesting discovery of my thesis is that I found increased apoptosis in 
trigenic embryo pharyngeal arches, not in the OFT cushions even thought both 
tissues have cells contributed by Peri-Cre lineages. One explanation could be 
 114
that TGFβ superfamily signaling ligands or receptors are differentially expressed 
at these two organ systems. In the future, we want to check the expression 
patterns of a list of genes by in situ hybridization, including TGFβ superfamily 
signaling ligands and their receptors. Another explanation could be that the 
downstream target genes respond differently to suppression of TGFβ superfamily 
signaling. To test this possibility, we are going to microdissect the tissues from 
the heart and pharyngeal arches, and extract total RNA out of those tissues, then 
perform microarray assay to find out the differential expressed genes between 
the heart and pharyngeal arches. The results come from this future study can not 
only explain why there is differential apoptosis between trigenic embryo 
pharyngeal arches and the OFT cushions, but also give us hints of why 
requirement for TGFβ superfamily signaling in these two tissues is different.  
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